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Abstract
Under- conditions of intense fish culture it may be necessary to use antib iotics in order to
mitigate disease problems. In an effort to reduce the impact of antibiot ic res idual s on the
environment and to eliminate the risk of exposure of these residuals to the consumer
optimal treatment regimes must be developed . These regimes must account for the use of
different antibioti cs used on a wide range of species held under varying culture
conditions. Culture of the Atlantic rod (Gadus morhua) show s a great deal of potential
and at present litt le infonn ation is available on the behaviour of Oxytetra cycline (OTe)
in this species.
In an cffon to genera te baseline pharmacokinetic numbers and to determine the clearance
time from organs for aTein Atlantic cod two experiments were undertaken. Experime nt
I examined the pharm acokinetics oCOTe in Atlanti c cod following a single dose by oral
gavage {Per Os (PO» or intraperitoneal (IP ) injecti on. Eighteen fish were held at 1O"C
and administered OTe either intraperitoneal ly a dose leve l of 132.8 mg OTC! kg fish or
orally at a dose level of 134.5 mg OTCJ kg fish. Blood samples were taken at 0.5, 3, 6.
12. 36 and 72 hrs and analyzed for OTe levels us ing High Pressur e Liquid
Chromatography (HPLC) . Nonco mpamnental model ing identified a time to maximum
serum concentration (f-J for IP and PO administration of 18 hrs and 6 hrs respectively.
The shorter T-...: in the PO group as co mpared to the IP group is not as expected and may
have been the resul t of precipitati on in the injectable so lution. Maximum serum
co ncentrations (e,......) for IP and PO were 140.8 ppm and 1.04 ppm respectively. Th e
higher em.... in the IP group is as expected and both numbers are in the same order of
magnitude as literature values. The relative bioavailability of OTC was calculated to be
0.8%. This low value compares well with litera ture values for orally administered drugs.
T\4 for PO administration was calculated to be 184 hours. The PO T\4 value was then
used to prediet a cleara nce time forOTC of38.3 days from the serum and 55.5 days from
the muscle of cod. This number compares well with literature values and with results
from experiment 2.
Experiment 2 examined the absorp tion, distribution and elimination of oxytetracycline
from Atlantic cod held in seawater at temperatures of IO"Cand 10"C decreasi ng to :ZOC.
Fis h were administered OTC in the feed at a dose level of 120 mg OTCI kg fish over an
I I day period . One group of five fish were held as controls and fed nonmedicated feed.
The water temperature for half the medicated fish was maintained at lQoe and for control
fish and the other half of the medicated fish was decreased from lOoe to 2°C by daily
increments ofO.loC . Samples of blood, muscle, gonad and liver were taken on days I, 5,
10, 20,41, 61 and 101 and analyzed for OTe levels using HPLC . OTC in the gonad was
detected in one sample on day I only therefore no subsequent statistical analys is was
conducted . Data for the remaining three tissue types was grouped by samp le day and
temperature regime. OTe concentration for the tissue types was plotted versus time. A
two factor analysis of variance showed no significan t differences in OTC concentrations
betwee n the temperature groups for serum, muscle or liver. Lack ofa temperature effect
on antibio tic clearance is unusual in poikilothenni c animals and does not compare with
results found in the literature. Insufficient differe nces in water temperature between the
iii
two groups, as a resu lt of small daily increm ental de creases, are believed to accoun t for
this result .
There were significant differences in OTC concentration by sample day in the serum,
muscle and live r. A Scheffes multip le co mparison determined that in serum and muscle
the differe nces were between O'TC levels up to and inc luding day 10 and OTe levels on
and aft er day 20. In liver the differences lay betwe en ore levels up to and includi ng day
41 and ore levels on and after day 61. It was determi ned that clearance of OTe in both
temperature groups occurred in the serum betwee n day 20 and day 41. This compares
well with the predicted value from experim ent 1 ofJ8 .J days. Clearance from the muscle
in both temperature groups occurred between day 41 and day 61. This compares well
with the pred icted value from experiment I of 55.5 days . Clearance from the live r in both
temperature gro ups was still occurring up to day 101.
These resu lts indicate that residual s ofOTC in cod for both temperature group s fell below
the legall y accep table level of 0 .1 ppm by day 41 in the serum and day 61 in the muscle .
These fall wit hin the suggested withdraw al period of 80 days., at or above 10°C. for OTC
in salmon. They also indicate that a wit hdrawal period for OT e of 80 days may be
acceptable in cod held below lOoe. Clearance of OTe from the liver was not
co nsiste ntly be low legal limits in either temperature group within the sample period . This
indicates that w hen harvesting the liver of cultured cod exten ded clearance times should
be consid ered.
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1.0 Introduction
The Atlanti c cod (Gadus morhua) is a bottom dwelli ng gadoid which inhabits the cool-
temperate waters of the conti nental shelf (Scott and Scott, 1988). Cod has been the
co rnersto ne of the Atlantic Can adian fishery for 500 years during which time there have
been marked fluctuations in annual landings. In 1988, in an effort to alleviate marketi ng
prob lems assoc iated with thes e fluctuations, Sea Forest Plantati on Ltd. of Newfo undland
investigat ed the potential of cod farming. Co d were captur ed live during the hig h volume
tr ap seaso n in the spring and held and fed over the su mmer. Hig h qual ity fill et s then went
to marke t during the traditionall y low volume season oflate fall . Althou gh cod proved to
be a suitable species to farm Vibriosis became a problem under conditions of intense
cu lture .
Vibriosis is a disease caused by bacteri a belongi ng to the Vibrio spp.. It is co mmo n in
man y cultured species and causes the death of infect ed fish if not treat ed. T he antibiotic
of choice for treating Vibrios is is oxytetr acycl ine (a Te). O'I'C is a broad spectrum
anti biotic tha t is effective agai nst a rang e of Gram negat ive bacteria (Co mbes et al ,
1972). It is used extensively in aqua culture as it is relativel y effective, inexpensive, has
low toxicity and is easily accessible (Alderm an, 1988) .
The efficac y of not only O'I'C, but any ant ibiotic regim e, is dependent on the drug
reaching the target organ. This, in turn, is dependent on four factors:
• absorption - transport of a drug from site of application to syste mic blood supply;
distribution - transport of drug from blood to tissues and organs . Efficacy is
further dependent on the drug accumulating in tissues and organs at
concentrations adequate to kill OT inhib it bacterial growth. This concentration is
referred to as the minimum inhibitio n concentration (MIC) .
metabolism - enzyme mediated anabo lism or catabolism ofa compound; and
elimination - excretion of a compou nd from the body (Baggott, 1988).
These four factors represent the pharmacokinetics of a drug. Phannacokinetics is affected
by the properties of the particular drug, the biology of the host and the environmen tal
conditions in which it lives. Drug properties include such factors as molecular weight,
solubility , degree ofionization (pH and pICa) and chemical structu re. These affect a drugs
ability to be passive ly diffused, actively transported or metabolized (Guarino , 1987,
1991; Ingebrigtsen, 1991). Host factors inc lude the presence of metabolic or active
transport systems, plasma protein binding, fat or protein content of tissues and organs.
vascularization, gastric emptying time and nutritional status (Jacobsen, 1984; Grandel et
ai, 1989; Bjorklu nd and Bylund, 1990, 1991; Black, 1991; Uno , 1992). Species which
undergo profound changes in physiology (such as metamorphosis or smoltification) or
seasona l variations in metabolism may show variations in their ability to utilize a drug
{Bruno, 1989; McSwain, 1992; O'Hara et ai, 1997). Of the many envi ronmental factors
which can potential ly affect pharmacokinetics. the main one for poikilotherms is
temperature. Highe r temperat ures increas e the rate at which kinetic processes occur ,
lower temperatures decrease the rate {Bjorklund and Bylund. 1990 ; Burka et ai, 1997) .
Salinity also affects pharm acokinetics through its influence on bioavailability (EJema et
at. 1996; Burka et al, 1997) .
The widespread use ofOTC in aquacu lture implies the existence of an extensive database
on its therapeutic and chemical pro pertie s. This is not the case . The main body of work
co nducted has been on wannl tem pera te, freshwater species such as carp (Gre ndel et al
1987, 1989; Nouws et al 1992) or fresh water phase salmon and trout (Gro ndel et al,
1989; Bjorklund and Bylund, 199 0, 1991 ; Black et aI, 1991 ; Rogstad er aI, 199 1; Nouws
et aI, 1992; Uno, 1996; Uno et aI, 1992 , 1997) . This impacts on maricu lture activities in
that regimes for cold! temperate, salt water species are often based on pharmacological
assumptions from warm! tem perate, fresh water species . Di fferences in drug disposition
indicate that extra polatio n of data among species may be inval id (Ingebrigts en, 1991;
Uno et aJ, 1992). Inappropriate admi nistration ofa drug may also lead to problems with
environmental buildup (Bjorkl und et aI, 1991; Rogstad et aI, 199 1; Hektoen, 199 5) and
bacterial resistance (Lunestad et aI, 1990 ; Smith et ai, 1994).
For cod aquaculture it is inte nded tha t the liver and gonad, in addition to the fillets, will
be marketed. Because there is varia bility in clearance times for OTC, not only among
species but between organ systems as well, the industry must work to ensure tha t the y are
in compliance with the legal limit of 0.1 ppm for OTC residuals wh en setting wit hd rawa l
times . This study , precipitated by a lack of published data, re presents a preliminary effort
to establish a pharmacoki netic database for cod. This data was gen erated by co nduct ing
two experime nts.
Ellperiment 1: Pharma co kinetics of oxytetracycline in Atlantic cod (Gadus morhua)
following a single dose by oral gavage or intraperito neal injection .
This experiment was designed to map serum conce ntrations of OTC over time in order to
determine maximum serum co ncentration (C-x). time to maximu m co ncentration (T_ .) .
bioav aitabi lity (F) and elimination half-life (T '4). This would allow for the generation of
prel iminary estimates of clearance time for OTC from the blood and muscle of cod.
These numbers were sub sequently co mpared to the results of experiment 2 and with
literature values for compara tive purposes .
Ellperiment 2: The absorption. distribution and eliminatio n of oxytetracycline from
Atlant ic cod (Gadus mo,hua) held in seawater at temperatures of constant 10°C and IOoe
decr easing to ZOC.
This exp eriment was designed w ith three aims. To : 1) determi ne whether the absorption.
distri bution and eli minatio n of oxytetracy cline occurs differentiall y at two temperature
regimes. One regime mimicked that ofa cod farm be tween August (high risk of disease at
10°C) and December (harvest at 2°C) and the second served as a controlled comparison
(constant seawater temperatur e of lO°C), 2) ide ntify the affin ity of OT e for different
organs, and 3) determine the elimination time, for regulatory purp oses, of OTe from the
serum. muscle. liver and gon ad of cod. These go als were achieved by admin istering O'I'C
to cod in the feed. Blood and org an samples wer e analyzed and the concentr ation of OTe
mapped over a 101 da y perio d. These numbers were compared to results from
Experiment I and to literature values for compara tive purposes.
This project marks the first time such pharmaco kineric experi ments were conducted in a
100% recircu lation, saltwater syst em. A high degree of effort was made to estab lish and
maintain the facility to experim ental protocols. In addition, these experi ments were
conducted to Good Laboratory Practice (GLP) standards . GLP is a set of regulations ,
enforce d by law in the United States. which are desig ned to ensure the qua lity and
validity of non-clinica l laboratory studies of materials intended for market . GLP
guidelines deal with the test facility , its personnel . the Standard Operating Procedures
(SOP s), the performance of the study, the reporting of study results and the archiving of
records and materials. It is antici pated that GLP (or its equivalent) will be implemented in
Canada. When that happens. experiments not cond ucted to GLP specifications will be
invalid insofar as regulatory proced ures are concerned . This experiment was conducted to
GLP standards in order to familiarize all parties concerned with the procedures required
and to commence building a database for pharm acoki netics in cold, salt wate r species
whic h wou ld have a high degree of validity from a regulatory standpoint .
2.0 Materials and Methods
A total of 189 Atlantic cod (Gadus morhua), targeted weigh t of 2 kg, were obtained from
Sea Forest Plantation's grow out site at Bay Bull s, Newfoundland o n January 4, 1995 and
land trans ported to the Atlantic Veterinary College facilities in Prince Edward Island
where the y arrived on January S. 1995. Upo n arrival the fish wer e randomly assigned to
nine L9 ml fiberglass tanks in either of two 1000/0recirculation unit s (Modul es 7 and 8).
Temperature durin g transpo rt was 2. 1°C and the arrival temperature was 3.O"C in Module
7 and 4AoC in Modul e 8. The temperatures afthe module s were raised over the co urse of
the holding peri od unt il the experi mental temperatures of lODe were reached .
All fish were tagged three weeks after arrival in the facility. The fish were fed moist
pe llets or chopped herring ad libitum ove r the course a f the acclim ation period . Dissolved
oxygen levels in all tanks wer e maintained above 8 ppm.
2.1 Pharmacokine tics
Eighteen fish were used in this experiment and had been held for 74 days prior to the start
of the experiment. Spawning was in progre ss and fish were feed ing at 1.0"/0 body weight
moist pellet s! day on conunencement of experiment (Appendix I) . Food was denied for
two days prior to the start of the experiment.
The fish were divided equally into two tanks on March 3 (three weeks prior to
experiment start) at which time the average weights were 2755g in Tank 2 and 3443 g in
Tank 3 (Append ix 2) with stocking dens ities of 13.lk gf m3 and 16.3/ m3 respectively.
Water temperature s in both tanks were 6.9"<; fourteen days prior to commen cemen t,
7.2"C seven days prior to commen cement and 10.O"Cat commencement of experim ent
(Appendix 3).
aTC for IF administration at a dosage level of 132.8 mgt kg fish was prepared by mixing
10.79 grams ofOTC·HC I wi th double disti lled ~O to a total volume of50 mL . A period
of approximately 1.5 hours elapsed from time of solution preparati on to injection by
which time some precipitati on of the solution had occurred .
For orally administered (PO) OTC, a modified Luer Monovette syringe with an out side
diameter of 15.3 mm was used for delivery . The feed! OTC mixture was made up using
herring which was thaw ed and processed into a paste. The paste was premeasured into
labeled syringes to the 3/4 mark. The weight of each fish was determined (Appendi x 2)
and the requisite amou nt of OTC inject ed into the syringe. The remaining volume in the
syringe waspacked with herring paste . Fish were orally gavaged at a dosage level of
134.5 mg OTCI kg cod (Appendix 4).
Dose levels were to have been 120 mg OTCI kg fish . A calculation erro r result ed in the
admi nistration of higher doses. As these doses were at clinical ly acceptable levels and of
the same order of magnitude for bot h group s the numbers were used in subsequent
pharma cokinetic calculati ons. They are not consider ed to have impacted on the integrit y
of the experiment .
For intraperitoneal ly (IP) administrated OTC , Hamilton Micrchtre Syringes (cal ibrated to
0.1 milligram precision) were used. On administration, fish weight was determi ned
(Appendix 2) and the requisite amount ofOTC was aspirated into the syringe . FISh were
inject ed at a dosage level of 132.8 mg OTCI Kg cod (Appendi:x5) .
To collect and hold fish for administrati on of the OTC and blood sampling, a 1- mesh
vexer barrier was placed in the holding tank. dividing it into three compart ments of
adjustab le size. The fish were held in one compartme nt. Fish were dip-netted and
anaesthet ized using MS222. Anaesthetized fish were weighed and the weights used to
calculate the appropriate dose for the PO and IP groups .
For PO administration, the syri nge was prepared with the appropriate amount of OT C
sandwiched between two Layers of herring paste . The syringe was placed in the
oeso phagus oft.'le fish, the plunger depressed and dose delivered, Fish were then placed
in an oxygena ted recovery bath and monitor ed for signs ofregurgitation and stress for IS
minutes. After recovery, the fish were returned to compartment 2 of the holding tank.
Nine fish were orally gavaged.
For injected fish, the requisite amou nt of OTC was aspirated into the syringe and fish
injected inuap erltonea1ly on their left. ventral side . These fish were also placed in an
oxygenated recovery bath and monito red for signs of stress for 15 minutes . After
recovery the fish WCf"e returned to compartment 3 oCthe holding tank... Nine fish were IF
injected .
Blood sampling started at hr 0.5 for the IF group and at hr 3 for the PO grou p. Samples
for both groups were taken thereafter at 6, 12, 18, 36 and 72 hrs (Appendix 6). Each fish
was samp led for blood twice in order to obtain the requisite data. At the scheduled time s
fish were removed from the appropriate tank comp anrnent and anaesthetized in MS222 .
lbey were placed, ventral side up, on a damp sponge and 5 mL of blood extracted by
venipuncture ofthe caudal vein. After the 0 .5,3,6 and 12 hr blood collections. fish were
revived in an oxygenated recovery bath and returned to the housing tank. On co mpletion
of the 18, 36 and n hr blood collections. fish were euthanized by submersi on in the
MS222 anaesthetic bath until IS minutes after last signs of opercular beat. Necropsies
were performed on all fish.
Blood was collected from the fish using 24G1 I Y.l • need les with Sec barrel s. The blood
was held in 5 ml lithium heparin vacu tainer tube s until centrifuged . Lithium heparin is an
anticoagulant which normall y does not interfere with HP LC analys is. Blood samp les
were transferred from the syringe into a lithium heparin vacutainer and stored on ice. On
complet ion of each blood collection, sam ples were centrifuged in a Beckman TJ-6
Centrifuge at 2,700 RPM for 2S minutes at ambie nt temperature. Plasma was then
pipert ed from the vaeutainer tubes into labe led ayovial tubes and stored at -200<:until
analysis .
All p lasma samp les were analyzed using High Pressure Liquid Chro matograph y (HPLC)
with a method refined for cod serum to a Limit of Detection (LoD) of 0 .05 ppm
(Appendix 7) . The instrumentation used was a Perkin Elmer ISS· IOO HPLC syste m with
a Series 410 LC pump. an LC 90 UV Spectrophotometric Detector and an LCI-l oo
Laboratory Co mputing Integrator . Spiked serum samp les were run to determi ne the
recovery levels of the HPLC procedure (Appendix 8).
Results were recorde d and graphed using QuattroProPlus. The data were modeled using a
least square s, nonlinear regression package. PCNONLIN version 4, SCI. This package
was made available courtesy of Dr . Tor Horsberg, Norwegian Schoo! of Veterinary
Medicine , Oslo . Modeling was noncom panmental with extravascular administration.
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2.2 Temperature
Atlan tic cod WU"e held for 133 days in a 100-10 recircu lated saltwater system prior to
co mmencement of tbe ecpe:rimern.. During this time water" tempe:ratures were raised from
3.00c in Module 7 and 4 .4°C in Module 8 to 10.1"C in both mod ules (Appendix 9) .
Wat er quali ty was monito red continuously and on commencement of experi ment Oz
leve ls were at 9.4 ppm and 11.4 ppm in Modul es 7 and 8, respecti ve ly, and un-ionized
amm onia levels were at 0.0 1 mgll .
The fish had completed a spawning eve nt duri ng this period . Org anic loading in the
recirculation system resulted in poor water quali ty with a subsequ ent total mort ality of
106 fish out ofl7l over the acc limati on period. Mortaliti es had stab ilized to zero over the
month precedi ng the experiment.
Sixty five fish were used in this experiment, The y were weig hed on Marc h 29 (A ppendix
10) and a sub-sample of 9 fish was again weighed on May 2 (Appendix I l) . An average
we igtu decrease of2_6% was calcul ated and this number was used to determi ne the OTe
dosage fOTthe experiment. Ten fish each were allocated to six 1.9m) tanks. These were
the experi menta.l fish . Five control fish were allocated to a separate 1.9m) tank. The
stoc king densities fOT the fish ranged from 9.6 kg.' m) to 14.9 kg.' m).
O f the experi mental fish, thirty were main tain ed at IO"C throughout the experim ent
(co nstan t temperature grou p) . Wat er temp era tures for thirty experi mental fish and 5
control fish were decreased fro m IO"C, by O. IOC daily, to 2"C on the fina l sam ple day
(decreasing temperature gro up). The water temperature regime of the decreasin g
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temperature group was calcu lated from the avera ge dai ly te mperatures at a cod farm site
between Au gust and Dece mber, 1992 (Appendix 12).
The co nstant temperature grou p, decreasing temperature grou p and co ntro l fish were held
at IO"C for the II day period during wbich the OTC was ad ministered (Appendix 13).
For delivery of the OTC to all experimental fish, OTC -HCL was injected into the body
cavity of who le smelt in quan tities calcul ated to deliver 120 mg OTC/ kg cod . The smelt
wer e stored at -20"<: in plast ic bags in a freezer and were remo ved four hour s prior to
feedi ng time and thawed. The order of delivery to tanks was rando m. The water was
disturbed by hand and smelt offered slowly to the cod . Th e fish were closel y monit ored
and non-feed ers were gav aged. Due to excess ive noise in the tank roo m on
Adm in istration day S, feedin g was cancelled for the da y to allow fish to reacc limate. As a
result. the 10 day regime o r OTC was administered over an t 1 day period.
Variati ons in temperature co ntro l resulted in a O.SOC difference between the two
temperature grou ps at sample da y 10 when there should have been a IOC difference. As
this was not consi dered signi ficant. fish from the two temperature group s were sampled
as a co mmo n temperature grou p (to"C) to sample day lO. Thereafter they wer e sampled
as two tempera ture groups: IO"C (co nstant temperature) and 1O"C decreasi ng to 2"'C
(decreasing te mperature ) (Appendix 14). The fish were lethall y sam pled at hour 12 and
on da ys S, l a, 20, 41, 61 and 101. Fish to be sampled were select ed rand oml y from
within the sampl e groups using Minitab generated numbers. On the final sampl e day the
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weights wen: record ed for the 1O"C decreasing to 2"C group. 1O"Cgroup and the contro l
(Appendix 10) .
Sampled fish were placed in an anaesth etic bath of MS222 and left until moderate
anesthes ia was achieved. Blood was tak en via caudal venipuncture using 5 mL syringes
with 24G1 1 'h.- needles. The blood was held unti l centrifu ged in 5 mL lithium hepari n
Vaanainer®. Centrifugation was done in a Beckman TJ-6 centrifu ge at 2,700 RPM for
25 minutes at ambient temperature. Plasma was then pipett ed from the vacuta iner tubes
into labeled cryovial tubes and stored at -20"'C until analysis.
Fish were then euthanized by submersion in the anaesth etic bath until 15 minu tes after
the last signs of opercu lar beat, transferred to a laboratory and dissected using aseptic
techni que. Samp les of liver, gonad and muscle were taken with double set s of tissue
placed individually in bags marked with the date , sample type, fish number and
destination, All samp les were quic k frozen and stored lU -2O"C in a controlled access
freezer. One tissue set was shipped to RPC Labo ratory lnc., Fredericton, New Brunswick.
On shipment day, ocgan samples were packed in insulat ed, heavy duty styro foam
con tainers with temperatures maintained below freezin g using medigrade ice packs .
Shipment was via air courier with trans it time maintained below four hours . The second
tissue set was stored at the Atlantic Veterinary College .
HPLC anal ysis was conducted by RPC Laboratory on serum (Limit of Detection (Lo D)
0.5 ppm] , musc le (LoD 0.05 ppm) , liver (LoD 3 ppm) and gonad (LoD 3 ppm) . Results
fro m the analyses were stored on QuattroProPlus. Data for the four tissue types were
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grou ped by sam ple day and temperature regime. Grou p means, standard errors and
standard deviations were celcelated. OT C concentra tions were plotted versus time for the
different tissue types.
The Box Cox procedure was om to examin e the shape of the observed data distributio n
and to identify any departu res from normality . A two factor analysis of variance was om
with sam ple day and temperature as the main effects . Significance was set at p=O.05. If
significant differences were found a Scheffe s multip le compariso n (po st hoc, two way.
pair wise p=O.05) was run to determi ne where these differences lay.
• 4
3.0 Results
3.1 Pharm acokinetics
On March 22 (initia tion of experiment) the average weight of PO fish was 2445 g and IP
fish was 30 12 g. This represents an average weight loss 0£ 310 g for PO fish and 431 g
for lP fish from the March 3 weights of2755 g and 3443 g respectively (Appendix 2).
The PO fish received, on average, 134.5 mg OTCJ kg fish (A ppendix 4) while the IP fish
received an averag e close or 132.8 mg OTCJkg fish (Appendix 5)
Exami nation of the data revealed an outlier in the PO treatment group at hours 3 and 18
( 17 ppm and 6.3 ppm respectively (Table 1). As thes e numbers were exce ssively and
inexp licably high relative to the others they were not used in the statist ical anal ysis . It
should be noted that these outliers were from the same fish sampled at two time period s
and this was the first fish gavaged. One fish also died in the PO gro up after the first
sample peri od. The average serum concentrations fOTthis gro up show an initial rise to
0.76 ppm at hour 3 with a slight rise to 1.04 ppm at hour 6. After this time the num bers
level out with 0.67, 0.61, 0.49 and 0 .68 ppm OTe at hour s 12, 18,36 and 72 respecti vely
(Table 2, Figur e 1).
One fish died in the IP group after the fir st sample period. The average serum
conc entrations rise initially to 67 ppm at hour 0.5 and decline to 44.8 ppm then 51 .2 ppm
at hours 6 and 12 respectivel y (Tab le 2, Figure 2) . A maximum concentration of 140.8
ppm is reached at hour 18. This falls to 64.9 ppm at hour 36 and rises again to 88.6 ppm
at hour 72.
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Necropsi es on all sampled fish revealed high levels of mucous in the gastroi ntestinal
The OTC recoveries on spiked serum samples using the HPL C method were consistently
high, ranging from 83 % to 108% (Appendix 8) .
Modeli ng using PCNONLIN gave the following result s: T-... for IP and PO
administration was at 18hrs and 6 hrs respectively. c....x for IP and PO was 140.8 ppm
and 1.04 ppm respectively. AUC for the 72 hour time period for IP and PO was 5802.5 hr
g1ml and 43.8 hr glm!. MRT (0-72 hrs) was 36.8 hr and 35.9 hr respectively (Table 3).
The relative bioavai lability of OTC was calculated to be 0.8%. T 'I.zfor IP administration
was calculated to be 154.2 hours. T 'I.zfor PO administrat ion wa s calculat ed to be 184
hours.
These numbers were compared to literatu re values generated from other pharmacokinet ic
experiments. A syno psis of pharma cokinet ic numbers found in the literature is given in
Table 4.
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Table 1: OI)'tetracyciine Levels (ppm) by Samp le Period (hrs) in the Serum or Ind ivid ual
Fisb for Intraperitoneal and Per Os Administration
March 22, 1995
March 23, 1995
March 24. 1995
Man:h25, 1995
Sample Period (bn)
0.'
0.'
0.'
J
J
J
6
6
6
6
6
6
12
12
12
12
12
12
18
18
18
18
18
18
J6
J6
J6
J6
J6
J6
72
72
72
72
72
72
17
Serum OTe Leve ls
" .3
71.4
65.4
0.67
0.85
17
0.79
1.46
0.87
46. 1
18.3
70
0.49
0.78
0.73
4.21
15.3
87
0.62
0.59
6.34
88.5
170
'"0.61
0.37
18.6
53. 1
l2J
0.47
0.87
0.70
lOS
72.1
Table 1: Anrace (hytetracydine CODteDtrations (ppm) ill th e Serum or F ish, Gr ouped by
Sample Period (hn), ror IP and PO AdministratioD.
Sample Interval (hrs) Avera e Serum Coecentrettcas m
IP PO
0.' 67.0
3 0.76
6 " .8 1.64
12 51.2 0.67
18 140.8 0.61
36 64.' 0.49
72 88.6 0 .68
1.2
~
o
~ _ 0.8
o E~! 0.6
:il 0.4
uS 0.2
o
/\
' \-.
-----------..-
o
o 20 40
Ti me (hrs )
60 80
Figure 1: Aver age O.q-tdutydine COllte nt ratiolls (ppm) ill the Ser um of fi sh (n=3 ),
G ro upe d by Sampl e Period (h n), for Per Os Admini~ration over time
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FiCllre 2 : Aver acc OIytetrac ydine Co ncen trations (ppm) in th e Seru m of Fish (n:3),
G r ouped by Sa mple Period (hrs), for Intr aperi tone al Administr ation ove r tim e
Table 3 : Pbarmacokine tic Parameters for Pe r Os an d Intra pe r itone al Adm inis t ra t ion of
OTCinCod
Av er a e Values Ma:l:im um Va lues Minimum Values
0.7 9
• mI
34.035
hr- u mI
1158 .84
hrs-u ml
Intr a Pe r Os
r itoneal
I'"
325\. 9
hr-u mI
40.7 hr
132466.2
~
' "
53.37
hr. mI
1.46
• mI
1957.59
..... ml
lotra Per Os
rh oneal
I' "170
u mI
35. 9 br
8389 .7
lu-. mI
301142.1
..... ml
1.04
u mI
3S.9 hr
43.77
ta-u mI
1572.48
lu'~
l a in Pu Os
ri toDcal
I'"
5802 .5
hr. mI
140 .8
u mI
21365 3.7
..... ml
~t;~I~84~±==:i===t===±==~0.8%Tmax concentration.
Cmax - Maximwn serum conce ntration (ppm)
AUC - Area under the curve
AUMC - Area under the concentration-time curve (first moment)
MRT - Mean retention time
T ",-Haltlifeofctimination
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Table 4: Summary orPublished PharmarokinetkParametersror O.ytetracydine fer Dirrerent Fish Species Heldunder Varyinjl
Environmental Conditions.
Species Researcner Year Salinity Temp. Roule Do" Tmax cmex T " Ellmlnaton F
(,~) (celsius) (mgl kg) (h~ (ppm) (h~ (days)
Atlantic BjOfldund& Bylund 1990 Fresh 13-17 Per os 100110 0 127
"salmon water
Rainbow Bjorklund&Bylund 1990 Fresh 17-20 PerCs 100/ 100 40.8 9
Iro", water
RaInbow Bjorklund& Bylund 1990 Fresh 5 PerCs 75 24 3.2 213 72
trout water
Rainbow BJOOJund& Bylund 1990 Fresh i o Per o s 75 12 5.3 " 6 41
trout water
Rainbow BjOOJund&Bylund 1990 Fresh 16 PerCs 75 , 2.' 115.2 27
Iro", water
Rainbow BJorldund & Bylund 1991 Fresh '6 Intravenous 2D • 113 60.3
Iro"' water
Rainbow BJOOJund& Bylund 1991 Fresh ' 6 PerCs 75 '2 2 74.9 5.60%
trout water
Rainbow Black. 1991 to Intravenous 5 o.5 18.8 81.5
trout etal
AtlanUc Elema
'990 Salt 7 Intravenous 20 50.4
salmon
.ta' water
Atlantic Elema 1996 Salt 7 Per os 50 12 0..42 1.94%
salmon
.'01 water
cere Grondel 1987 Fresh 2. Intravenous 60 1 247.5 139.8
"01 waler
e"" Grondel 19a7 Fresh 2. Intra 60
"
58.8 78.6 80%
.'01 water muscular
e.", Grondel 1987 Fresh 2. Per Os eo 2. 0.11 0.60%
.'01 water
Aflican Grondel 1989 Fresh 25 Intra 60 7 43.4 74.4 65%
catfish eta/ weter muscular
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SpeCIes Researctlflr Vear SallnRy Temp. ROlJle D, ,. rmex cmex T 111 Ellmlnaton F
(PI'I) (celsius) (lTllV kg) II«) (ppm) Ih~ (da)'t)
Rainbow Grondel 1989 F,,"' 12 Intra eo • 56.9 94.7 80%lto<rt .10' waler muscular
African G...,." 1989 fresh 25 Intravenous 60 0 ,O? 80.3
calfish etsl water
Rainbow Grondel 1989 Fresh 12 Intravenous 60 0 7531 89.5
'ro~
""
water
Atlantic MCSwain (MSc) 1992 Sail 15
''''"
100 , 31.5 56.' 85.8 m~hr
..-
water artel1a1
AlIantlc McSwIin (MSe) '''2 S., 10 Intra 100 , 39.9 62.2 8O.5mlfhr
salmon waler artel1a1
Atlantic MCSwain (MSc) 1992 S. h 10 P" ", 100 , 0.22 12.5 5522 mt/ 1.5Mt
salmon waler hr
All. ntlc MCSwain (MSc) 1992 S. h 15 eeros 100 , 0.77 171.6 933.4mlf 7.40%
salmon water
'"Allantlc MCSwain 1992 S. , 15 tntra 100 , 31.5 '2
salmon
""
water alterial
AtlantIc MCSwain
""
S., 15 Per Os 100
" 'mon
""
waler
C.", Nouws 1992 Fresh 21l intra 80
"
57
"
""
water muscular
C.", NOUW5 1992 Fresh , Intra eo ,
"
157
.,,, waler muscularE., No.... 1992 FreSh 22 Intra
"
18 100 '96
""
waler mllSCUlar
RaInbow Nouws 1992 Fresh 10 Int.. eo 10 35 150
''''''
.,,, waler muscular
eo", N""" 1992 f resh Intra eo • es 36.,,, waler loontoneal
C.", Nouws 1992 Fresh 20 Intravenous eo >100 52
.,,, waler
11
-Researcher Year 5alinMy Temp. R"", oese 'rmex crnex T ,n EllminBlon F
(ppt) (celsius) (mgl kg) (h~ (ppm) (hr) (days)
C,,,, Nouws 11192 Fresh 8 Intravenous 60 >' DO '89
etal water
Rainbow No.... 11192 Fresll
"
Intrallenous 60 >100 76
""" ""
water
Rainbow Nouws
""
Fmh 10 Intravenous 60 >' DO 130
,rout
""
Wiler
Rainbow ...... ,.., Fresh 10 Per Os 80 .. 0.35 50 1.25%
lrout ,.., wl lef
C. ", N_ ,.., Fmh 20 Per Os 80 24 0.46 58 0.36%
""
water
Rainbow Rogslad 1991 Fresh 1 Per Os I '50 12 ' .1 278.4 >1.. 2.60%
lro~ ,.., water casulll
~A=~lveliS Uno "00 Fresh 18 Per Os / 100 34.2 53.1 9.60%
water cansule
P.altiveUs uno "00 Fresh 18 Per Os! 100 2.17 83.2 3.80%
IA" waler 'u••
~A:IiS Uno
''''
Fresh 18 Intravenous 2S 0 122 52.1
waler
Rainbow Unoet 81 1897 F"'h 13 Intt8Venous 50 0 331
",rout waler
Am... Uno etal ,.., Fro'" 13 Per OS ' 00 24 2.05 18
salmon water
Rainbow Uno9t al 1'192 Fresh 13 PerC s ' 00 • 1.14 23,2 0 .80%trout water
Vel owlail Uno ef aJ 1992 S., 22 PerOs ' DO 3 0.89
"water
Gadus VatcherfRalnnle 1995 s., 10
':;:oneal 132.8 18 140.8 154.2 0.80%mortlua water
Gadus Vatcher/Ralnnle ,..s S" 10 PerOs 134.5 8 1.04 ,"
"momua water
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3.2 Temperature
Gonadal concentrations of aTe in the experimental fish were at 1.0 ppm at Hour 12
(Table 5). There were no detectab le leve ls of OTe at days 5. 10, 20 , 41, 61 or 101.
Seru m eoeceetrau cn s of OTe in the experimental grou ps rose from 0. 8 ppm (standard
erro r 0.2 ppm) at hour 12 to a maxi mum concemntion of 1.3 ppm (standard error 0.2
ppm) at day 5 (Table 5). At day 10 OTe levels were at 1.2 ppm (standard erro r 0.3 ppm).
After this point the groups were sampled as two temperature effects. Levels in the
constant temperature group were at 0 ppm on day 20, 41, 6 1 and 10 1. The decreas ing
temperature group had 0.1 ppm (st andard error 0.1 ppm) on day 20 and 0 ppm on day 41,
6 1 and 101. The average serum concentrations of OTe in the experimental gro ups by
samp le day show a Tmuc at day 5 wit h a e-..of 1.3 ppm (Table 6; Figure 3).
Muscle concentrations of OTe ro se stead ily from 0.43 ppm (standard error 0.16 ppm) at
hour 12, 0.51 ppm (standard erro r 0.13 ppm) on day 5 and peaked at 0.76 ppm (stand ard
erro r 0_23 ppm) on sample day 10 (Tab le 5) . After this poilUthe gro ups were sampled as
two temperature effects. The constant temperature group was at 0 .14 ppm (standard error
0 .05 ppm) , 0.02 ppm (standard erro r 0.01 ppm), 0 ppm and 0 ppm on sample days 20,
4 1, 6 l and 101 respectively. The decr easing tempera ture group was at 0.18 ppm (standard
error 0.07 ppm), 0.08 ppm (standard error 0.05 ppm), a ppm and a ppm on sample days
20, 41, 61 and 101 respectively. The average muscle concentrations of O'FC in the
experimental groups by sample day show a T......at day 10 with a e.-,. of 0.76 ppm (Table
6, Figure 4).
Liver OTC concentrations rose steadi ly from 7 ppm (standard error 2 ppm) at hour 12 to
15 ppm (standard error 0.7 ppm) at day 5 to a maximu m concentration of 42 ppm
(standard error 6 ppm) at day 10 (Tab le 5). After this point the grou ps were sampled as
two temperature effects. The constant temperatu re group was at 28 ppm (standard error 5
ppm) , 27 ppm (stan dard error 8 ppm), 2 ppm (standard error I ppm) and 0 ppm on
sample day 20, 41, 61 and 101 respectively. The decreasing temperature group was at 17
ppm (standard error 8 ppm), 17 ppm (standard error 3 ppm), 0 ppm and 1 ppm (standard
error 1 ppm) on samp le days 20, 41, 61 and 101 respectively. The average liver
co ncentrations of OTC in the experimental groups by day show a Tnwo: at day 10 with a
Cmax of 42 ppm (Tab le 6; Figure 5).
One contro l fish died during the experiment . Liver samples in one co ntro l fish at day 5
and one co ntrol fish at day 10 had residua ls ofOTC (Table 5).
Anal ys is of the observ ed data distribution patterns from the Box Cox procedu re indicated
that a Gompen s Transformation ( 11 SQRT(Log X+1.5) was required to normalize the
data . The two factor (sample day and temperature) analysis of variance showed no
significant differences in GTC concentrati ons between the temperature groups for serum
(Table 7), muscle (Tabl e 8) or liver (Table 9). There wer e significa nt differ ences in OTC
co ncentration by sample day in the serum (Table 7), muscle (Table 8) and liver (Tab le 9).
A Scheffes multiple comparison detennined that in serum (Table 10) and muscle (Table
II ) significant differ ences lay were between OTC leve ls up to and including day 10 and
OTC levels on and after day 20. In liver (Table 12) significant differences were between
OTC levels up to and including day 41 and OTC levels on and after day 61.
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T ab le 5: Concentrations of Osytetracycline (pp m) , Grouped by Sample Day and
T em perature Rqime, in th e Serum, Musc le, Liver and Gonad of Ind ividual Fisb With
Me an Standa rd ErTor and Standard Deviation
Sam ple Tem pel'2tufe F.... Ocr CODttlltratiOD ro
Do, G~ Number S<ru ro MU5(:le Livcr Gonad
1 Common 1 0 0 .17 5 0
1 Ccmmcn z 0.5 0 .21 0 0
1 Cemmcn 3 I.' 1.24 , 3
1
""--
. 1 0. 18 n 0
1
""--
, 0.9 026 13 0
1
""--
6 1.> 0. S2 . 0
~ 0.8 0.43 7 10.' 0.38 5 10.1 0.16 1 0Colltrol 7 0 0 8 0
""--
8 LI 0.5 2 11 0
5 Common 9 1 0 . 0, <:0=ca 10 U 0. 89 8 0
, Common 11 LS 0.s5 , 0
~ Common 11 0.7 0 .6 1 4S 0L3 O.Sl is0.' 0 2 9 is0.1 0. 13 7Control 13 0.5 0 18 0
1 Cemmcn 14 1.3 0. 25 38 0
10 Common rs 0.' 1.28 63 0
10 Common 16 LS 0 ." 34 0
10 Common 17 1 0 .21 51 0
10 Common 18 0.8 1.4 1 15 0
A 1.1 0.76
"St. 0.6 0 5 13
e, 0.3 0_23 6
1O"C
"
0 0 .06 13 0
10 1000C 10 0 0 .32 19 0
10 1000C 11 0 O.ll 0
10 IO"C 11 0 0 .19 0
10 1000C 13 0 0 41 0
~ 0 .14 18O.ll 110. 05 ,1"C 14 0.5 0 .49 14 01"C 15 0 0 .08 3 0
1"C 16 0 0 .14 0
10 1"C 17 0 0 .12 , 0
10 1"C 18 0 0 .08 46 0
Mao 0.1 0 .18 17
SL Dcviation 0.1 0 .16 17
SLE rror- 0. 1 0 .07 8
"
ic-c 19 0 0 31 0
16
5&nJplc Tn-pcrabIrt ".. ocr CoacealntiollDO' G~. N. ..... ...... Mud< u.... ......
41 IO"C JO • e.cs "
0
41 1O"C JI • O.O~ 26 0
.. IO"C J2
·
• " •.. IO"C ]]
·
0 7 0
.. IO"C
" ·
0
"
0
M= 0.02 27
5t. Devial:ioD 0.03
"Sc _ 0.0 1 •
.. 'OC
"
0 0.13 za 0
.. ' OC 26 0 0.33
"
0
.. ' OC J7 0 0 , 0
.. ' · C
"
0 0 26 0
.. ' OC
"
0 0 17 0
41 ' OC eo 0 0 is 0
M~ 0.08 17
St.DeviatioQ 0.12 7
st.ueor O.O~ 7
61 ro-c .. 0 0 s 0
61 ro-c 42 0 0 , 0
61 ro-c .o 0 0 0 0
61 ro-c
"
0 0 0 0§i ro-c " 0 0 0 0,sc ,1
, OC .. 0 0 0 0
, OC 47 0 0 0 0
a-c .. 0 0 0 0
z-c ., 0 0 0 0
a-c so 0 0 0 0
h eoa... "
0 0 0 0
~
' O"C
"
0 0 0 0
1O"C
"
0 0 0 0
IO"C
"
0 0 0 .
IO"C
"
0 0 0 0
IO"C 56 0 0 0 0
IO"C
"
0 0 0 0
~ 2"C ss 0 0 0 0
101 2"C
"
0 0 3 0
101 '·C 60 0 0 3 0
101 , OC 61 0 0 0 0
10. ' ·C
"
0 0 0 0
17
......
D• •
10 1
10 1
F;"
NVlIl w
"..
se~
o
o
OCTCoocarratioa ..
M li sde Lner
o 0
o 0
Goa..
o
o
......
SL DeviaDoo
S<Emr
T ab le 6: Avera&<, Senna Coo ceu tr atio u of Oxytetncycliae (ppm), Grouped by
Tempeuture lUVme an d Sam ple Day. ill the Senua, Musd e, Live r aDd Gooad of FlSb
"'pl< Tem peratu re 0 Coattatntioll mD'~ G~ ...... Muscle ...... Goa . ,
I
c._ _
0. ' 0.43 7 I
5
c.__
I.J O.SI 15 0
10
c.__
1.2 0.16 42 0
20 Tcn DeereasUtIl10 0 0.14 28 0
T~ 0 1 0.11
"
0
41 TenDea'easingto 0 0.02 27 0
T~ 0 0.08
"
0
61 Ten D«: reas ing 10 0 0 2 0
T~ 0 0 0 0
101 Ten Dcacasing lO 0 0 0 0
T~ 0 0 I 0
"'D 0 .5 O.OS 3 3
Table 7: Results of the two ractor ANOVA testi aC tbe fi red. of Day, Tempcn lvre, and
(olen m oa 00 t he CODcet:ltr at ioo ofO¥)'tcrr aeydioc (ppm) ia th e Se ru m of rlSh .
T1ItoF actorAIW . rl Va rialM:e <0.
I:fl'tct DF*
I
FV....
0.161
51 if"1Ca.ItCe*
NS
5
NS
0.0001
0.ssec
60."
0.lS2
.. ,
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RcsiduaI 62
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T ab le 8: Resu lts DC tbe two Cactol;' ANOVA tesueg th e effect of n a y, Tem peratu l:'e, and
Inter acti oDon tbe Concentr ati oD of Oxytetracycli ne (ppm) io tb e M uscl e of Fisb.
TwoFactol;'An'" lisof Vari lUll:e
Etrcd DF~
T= I
6
6
62
FV"'ue
0.135
18.735
0.060
PV.....e
0.7150
0.0001
0.9991
ofFrecdom.
Si cance·- "SMdenotesaSlatistit:al.l si cant result,
Ta ble 9: Results of tb e two rect or ANOVA tes tin g th e effect of Day, Tempera ture, and
Int era ction 0 11 the Co ncentra t ion of Oxytetracycli ne (pp m) in th e Liver of Fish .
FVlllue
0.0004
19.372
l.012
PValue
0.9838
0.000 1
0 .4261
Ta ble 10: Sch effe's pair-wise com pa l:'isons for Eff ect of n ay (P<O.OS) on th e Co ncent ra tio n
of Oxytetra cycl ine (ppm) in the Serum of Fish
D. 1 s 10
"
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", N5
10 N5
zo 5 S
4 1 5 5 NS
61 5 5 N5 N5
101 5 5 N5 NS N5
51 = ' -S"'dcnotes a • c:antresul t.
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Table 11: Scheffe's pair-wise compari sons for Effect of Oay (P<O.05 ) on the Concentration
ofOxytetracydin e (ppm) in the Muscle of Fish.
D. I s 10 10
"
61
s NS
10 NS
10 NS 5
"
5 5 NS
61 5 5 NS NS
101 S S NS NS NS
Si =~" "S't denctes a =We
Table t:z: Sche ffe's pair-wise comparisons (or Effect of Oay (P<O.05) on the Concentratio n
of Oxyt etracycline (ppm) in the Liver of Fish.
D. 1 s 10 10
"
61
s NS
10 NS NS
20 NS NS NS
"
NS NS NS NS
61 S 5 S S S
101 S 5 5 S S NS
Si = " ~S"dcnotcs asta lislicallv si earnresult,
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Figure 4: Average O~etraeydine Concent rations (pp m), with Standard Er ror Bars , in th e
Musde ofFish Over Time (Days;
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4.0 Discussion
4.1 Pharmacokinetics
The graphed data from PO administrati on of aTe reveal a curve with a rise in
concentration to 1.04 ppm aTe at bour 6 and a steady decline to 0.49 ppm at hour 36.
The slight rise in the terminal porti on of lhe curv e occu rred after the ant icipated point of
absorption of OTC in the serum . PO serum curv es often manifest as a small peak with a
slow but steady dec line to negligible residues (Gro ndel et ai, 1987; Nouws et at 1992;
Uno, 1996). Dissection s of the cod followi ng the final samplings revealed that the
herri ng paste was partial ly digested at the 36 hou r sample period and was fully digested
by the 72 hour .sample period. This indicates that digestion was occurri ng within the
norm al range of 24-48 hrs at lOoe (Ellis et ai, 1989). There were , however , large
quanti ties of gastrointestinal (GI) mucou s. GI mucou s has been noted in non-feeding and
newly feeding farmed co d (Brian Blanchard, Pers . Corron.). Feeding in wild and farmed
cod is grea tly reduced duri ng the winter and thr oughout the spring spawning event. The
cod used in this experiment were transported in January at 2.1"C and accl imated to IDee
over a 74 day holding period . At the stan of the experiment the cod had just completed
spawning and were still at low feeding levels (1.0% body weight! day moist feed as
opposed to the nonnal daily intake of5% body weight! clay). The presence ofGI mucous
was, there fore, not considered unusual however the mucous may have interfered with the
efficiency of absorption of OTe across the gut wall. Ingebrigtsen et at (1985) fed
radiolabeled tetracycline to fish and then followed its flow through the organ systems.
They found that er day 2 the re had been negligible absorption of the OTC; most of it
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resided in the mucosal lining of the gastro intestinal tract. This may result in a pro longed
absorptio n phase of OTC to systemic circulation and exp lain why the OTC in this
experiment was still being absorbed past the final samp le period.
The grap hed data from [P administration reveal a curve with a double peak: at hours 0.5
and 18 (at levels of67 ppm and 140.8 ppm respectively). Although the concen trat ion of
OTC declined rapidly to 64.9 ppm at hour 36, there was a slight rise in the tennin al
portion of the curve to the final sample point . This differs from published data in that
most absorption curves (intravenous, intraperitoneal or intramuscu lar) are manifested as a
single peak immediately after injection wit h a steady decline to negligible residuals
(Grendel et al, 1987. McCracken et aJ, 1975. Uno, 1996). In this experiment, the first
peak occurs at 30 minutes after injection, which is in line with published figures . The
second peak at 18 hours is an anomaly and may be the result of precipitatio n of OTC in
the injected solution. OTC which remained in solutio n was absorbed immed iately;
precipitated OTC was not absorbed until it dissolved. The presence of precipitous
material in the viscera of dissected fish at 72 hours supports this theory. This may also
have contributed to the rise in the curve to the final sample period .
A phys iological contributio n to the pattern of absorptio n (and therefore the shape of the
curve) for both types of administration may have been enterohc:patic circulation. This
describes the process whereby a compoun d, such as OT C. is recircula ted betwee n the
gastroi ntestinal tract and the liver. OTC is transpo rted in blood via the hepat ic portal
system from the intesti ne (for orally administered drugs) or from systemic circulation via
the coeliac artery (for IV, 1M or IP administered drugs) to the liver. In the liver it is
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metabolized or biotransfbrmed, actively transported to the bile and then excreted via the
biliary route into the intestinal lumen. It can then be excreted from the body via the
faeces or reabsorbed back into the liver via the hepatic portal system. This crea tes a loop
which allows for a portion of the compound to be reabsorbed and a portion to be
eliminated from the body with eac h cyc le. The rate of red uction of the compo und would
be dependen t on hepatobiliary functio n (lngebrigtsen, 198 5; Bruno , 1989; Ellis, 1989;
McSwain, 1992 ; Burica et ai, 1997) . Secondary peaks for PO data at I ScC support the
presence of an enteroh epatic cycle (McSwain, 1992). The cod used in this experiment
had just comp leted spawning and were in trans ition from a nonfeeding phase whe re
energy was being derived from the liver , to a feeding phase where a portion of the energy
was being directed to production of the liver. Long periods of food deprivation may
induce general changes in hepato biliary function (McSwain, 1992). Strasdine and
McBride (1979) found evide nce of diffe rential absorption between fasting (sexually
mature) and non-fasting (immature) salmon. The effect of hepatic metabo lism in species,
such as cod, which undergo marked seasonal variations in feedi ng and use the liver as an
organ of storage, might impact signi fican tly on the pharmacokinetics of a drug and bear
further investiga tion
There are two methods available fo r model ing phann aco ki net ic data : compartmental and
non-co mpartmental. In the classic co mpartmental approach the body is viewed as one,
two or three compartments with blood and highly perfused organs being the central
co mpartment. Drug transport betw een these abstract compartments occurs with
concentration differences acting as the driving force. The most frequently used mode l is
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the two compartment model which dictates that the plasma concentration curve satisfy a
hi-expon ential equation. The model paramet ers are clearan ce, volume and flow. Rate
const ants govern transport between compart ments. The majori ty of pharmacokinetic
wo rk in fish is modele d this way how ever the theoretical limitations of a model which
reduces the body [0 two compartments must be recognized . As a result of these
limitations, classica l pharm acokinetic models arc designe d to render conservative
estimates for the elimination of drugs . This provides a wide margin of safety for the
co nsumer but results in extended holding periods for farmers with recently treated market
fish. Bjork lund and Bylund (1990) predicted elim ination times of n , 4 1 and 27 days for
OT C from Atlantic salmon held at SoC, lOoC and 16°C respe ct ively using the classical
app roac h. Actual eliminatio n times were 40, 30 and 20 days. Thi s represents an
overestimation of27"/o to 45% in elimination time .
In non-compartmental pharmacokinetics the body is seen as an arrangement of organs
and subsystems through which blood flows and behaves as a system controlled by
positive feedback. The important paramete rs are the mean body transit time, cardiac
output, extraction ratio, clearance, number of recirculatio ns, mean residence time and
volume of distribution. Assumptions made abo ut the static nature of the body system are
greatly reduced in non-compartmental analysis. This mathemat ica l acknowl edgement of
the complex nature o f the body system requires an increase in the mathematical
co mplexity of the computer package with fewer associated assumpti ons. It also represents
a move towards increased precision in pred icting elimination times under changing
conditions of administra tion, dose, temperature, age, disease status and species of fish.
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This must be done while maintaining an acceptable margin of safety for the consumer .
Brockle bank et al (1997) compared the predicted elimination times of classical and
noncompartmental analysis for OTe in salmon. For a given dosage regime; the classic
pharmacokinetic approach predicted a 180 day withdrawal period, and the non-
compartmental a 108 day withdrawal period. Actual analysis of the tissues showed that
there were no detectable residues at day U8 . There were no samples taken on day 108.
Assuming that the OTe had not cleared by day 108, the noncompartmental analysis
rendere d an under-estimation of clearance time of9"lo. The classical approach rendered an
overestimation of 34% . It is importan t to move towards the increased precision of non-
compartmental modeling however given the variations in physiology within and among
species the collection of a more extensive database is required. Data in this experime nt
was modeled non-co mpanmentally.
In the following discussion it should be noted that there is litt le standardization between
pharmacokinetic experiments. Experimental difference s in design, data modeling, water
temperature, salinity. therapeutic dose; route of administration, species, individual size
and seasonal variations in physio logy make compariso ns between published numbers a
benchmarking proces s rather than a precise comparison. Table 4 provides a summary of
pharmacckineric experiments. Only one reference to OTe in nonsalmonid, marine fish
was found (Uno et ai, 1992).
Cmax is the maximum co ncentration of a drug found in the tissue and is measured in parts
per million (ppm). T-.; is the time (hi) to maximum plasma concentration and provides
an estima te of absorptio n rate for a given dosage form (Barron et ai , 1990)_In the present
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experiment. c....... for the IP group was calculated to be 140.8 ppm and occurred at a Tuw<
of 8 hour s. It is believed that the double peak in the curv e may have resulted in an
artificiall y high TlD&I<. This number should be regarded as a maximum value. In the only
other IP study found . Nouws et al (1992) reported a c....... of 65 ppm at a T..- of 5 hours
for carp held at 20 G C. The differences betw een that data and tho se found in this
experiment are due to several of the non-standardized factor s listed abo ve. Higher water
temperatures (20GC versu s l 00C) may have contributed to the short er TltIU than OUT data
and a co mbination oflower dose (60 mg OTC/ kg) and higher temperatures to the lower
c....x for the PO gro up was calculated to be 1.04 ppm and occurred at a T""",of 6 h OUTS.
These data fit well wit h the PO data of Uno et al (1992) who repo rted a e.-J Tm&>< of
1.14 ppm at hr 9, 2.05ppm at hr 24 and 0.89 ppm at hr 3 for trout, Ama go salmon and
yellowtail res pect ive ly. The Ta:w:I Cm&>< data also fit with those foun d for Atlanti c salmon.
Elema et al , (1996) reported a~ of 0.42 at a TlD&I< of 12 hours; McSwain ( 1992)
report ed two e..-valuesfor Atlant ic salmon : 0.22 ppm and 0 .77 ppm, both at a TII\2X of 3
hours.
Gfthe many factors which affect c...... and Tmu:the main one is rout e of administra tion.
emu is highe st and Tmu:shortest in intraveno us (IV) administered tr eatme nts, follow ed by
intraperi toneal (IP) , intram uscu lar (1M) and PO administered treatments. This is due to
the fact that in IV admin istration the drug is introduced directl y to the animals syste mic
circulation. In IP and 1M administration the drug is introduced to well perfused
compartments of the bod y and makes its way rapidl y to systemic circulati on . In PO
3.
administration the drug is introduced to the body via the feed through the digestive tract
where it makes its way to the circulation system. Depending on the drug and its
formulation this may resu lt in poor absorption and bioavai labi lity. In the case of
oxytetra cycline, it does.
IP administration in cod rendered a e.- of 140.8 ppm at hOUT 18 versus a PO e..-of
1.04 ppm at hour 6. The higher IP e..- relative to the PO e..- is as expected. The
delayed IP Tmax was a result of the double absorption peak . Exampl es ofe..- and TtllA.'<
from studies done using IV, IP, 1M and PO administration are provided in Table 4. In
carp held at 2o"e (No uws et al. 1992) C....,.for IV administration was >100 ppm at hOUT O.
IP was 65 ppm at hr 5. 1M was 57 ppm at hr 14 and PO was 0.46 ppm at hr 24. In the
same paper. trout held at lO"e had an IV administration e-,.. of > 100 ppm at hr O.1M of
35 ppm at hr 10 and PO of 0 .35 ppm at hr 48. The pattern of highest e..-and shortest
Tmax in order of IV to PO administration is well demonstrated. The same was shown in
the fo llowing experiment s. Grondel et a f (1987) held carp at 20"C and achieved an rv
C....,. of 247.5 ppm at hr 1, 1M c...... of 56.8 ppm at hr 14 and PO e-..ofO.ll ppm at hr
20 . Bjo rklund and By lund (l99 l) held trout at 16"e and got an rv C..,."of 113 ppm at hr
o and a PO c.....: of2 ppm at hr 12.
For oxytetracycline administered orally in a capsu le, Uno (1996) obtained a e..- of 34 .2
ppm in healthy Ayu. (time not specified). This relative ly high e..-may be due to the fact
that the OTe was administe red without the interacting effect of chelat ion with cations in
the feed. This wi ll be discussed further in the sectio n on bioavailability .
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Dose level also affects e-xwith high doses lead ing to higher maximu m concentrations.
This is suppo rted by the findings in this experiment of a e-.:of 140.8 ppm at an IP dose
level of 132.8 mg OTCf kg fish venus aCmu in carp (No uws et al, 1992) of65 ppm after
an IP administration of 60 mg OTC! kg fish. Rainbow trout injected intraveno us ly with
5mg OTC! kg (Black et al, 1991),20 mg OTC! kg (Bjorklund and Bylun d, 1991) and 50
mg OT C! kg (U no et at, 1991) rendered a e..-of 18.8, III and 331 ppm respective ly.
PO admi nistration in Rainbow trout of60 mg OTC! kg (NOUMi et ai, 1992) and 75 mg}
OTC (Bjorklund and Bylund, 1990) rendered a e..-of 0.35 and 5.3 ppm respectively
The PO Cmax of 1.04 ppm at a dose level of 134 .5 ppm found in this experime nt falls
betwee n these numb ers. Variations in experime ntal protocol would have influe nced the
Cmu.levels .
Temperature appears to affect T...... and c-... differentially. TIIIalC in Rainbow trout
(Bjorklund and Bylund , 1990) was achieved at hr 24, hr 12, and hr I at temperatures of
S"C, 10°C and 16°C respectively. Tma:< was shortest at 16°C and longest at SoC. This may
have been due to the increased metabo lic rates of fish at higher temperatu res. c....x,
howeve r, was highest at 1000C (S.3 ppm) not 16°C (2 .1 ppm). It was hypothesized that the
relatively low CIDaX at 16"C was the result of an acco rdingly increased excret ion rate. A
low Cmaxof 3.2 ppm at SoC may be the result of decreased fluidity o f the GI membrane
at lower temperatures with a subsequent reduction in absorpti on {lngeb rigtse n, 1991).
Species differences exist with respect to Cmuand TIDaX and may be due to differen ces in
muscle perfusion, fat and protein content (Grandel, 1987; Ingebrigtsen, 1991). Gre ndel et
al (1989) conducted expe riments with African catfis h (white flesh) and trout (redfl esh).
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1M injection of60 mg OTC! kg rendered a Cm.x of 43.4 ppm in African catfish and 56.9
ppm in trout. Experiments by Nouws et al (1992) with carp (whitefles h) and eel (high fat!
protei n fish) after a 60 mg OTC! kg 1M injection obtained a Cmax of 57 ppm in carp and
100 ppm in eel. The PO Cmax in this experiment for cod (whiteflesh) was 1.04 ppm
whereas trout at a similar dose and temperature was 5.3 ppm (Bjorklund and Bylund,
1990).
The last: major factor affecting Cmu: for orally administered drugs is salinity. High
salinities reduce bioavailability by chelation of OTC with divalent cations in the
seawater. This will be examined thoroughly in the sectio n on bioavai lability .
A facto r which may influence maximum concentratio n of a drug achieved in the body is
health status. Uno (1996) found that the e-x in healthy Ayu was 34.2 ppm and in
Vibriosis infected Ayu was 2.17 ppm. This may be due to damage of the GI tract by the
bacteria or toxin . This effect is particularly important when treating sick fish as a
reduction in Cmax could reduce the likelihood of attaining therapeutic levels (MICs) in the
target organ . Little work has been conducted on pharmacokinetics in sick fish.
Two mathematical concepts are used to calculate the elimination and elimination half-life
(TIn) of various drugs. The AUe (Area Under the Concentration vs Time Curve) and
AUMC (area under the first moment curve) are mathemat ical representations of the
graphed values. Beta is a derivation of
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Eliminat ion half-life (Till). is the time required for a giv-en plasma co ncentratio n to
decli ne by 50'% during the exponential. termin al phase of tthe drug concentration time
profile (Baggott. 1988). PCNONLIN calculates T 112 by conducting a nonlinear , least
squares. regression analysis of the data from T IZIaX to the last samp ling point. Due to the
unusual shape of the curve produc ed in this experime nt (do a rble peak wit h slight rise to
final sample point) PCNONLIN would not calculate beta or Till for the IP group.
Calculating this number by graphing the data and co nductin g a regress ion analysis from
TlDU to the final sample point rendered a T II 2 value of 15 4.2 hrs (6.4 days) for IP
admin istered OTC.
The PO TI12 was calculated by PCNONLIN to be 184 hrs (7 _7 days ). Becau se of the rise
in the termi nal portion of the curve this is considered an overesti mation of half-life.
Optim ally, the final sample perio d should extend beyond any rise in the terminal portion
ofthe graph in order to ensure that abso rption is complete. These values are . however, of
the same order of magnitude as the 146 hrs calculated for tnout held at lOoe (Bjo rklund
and Bylund. 1990); the 130 hrs and 150 hrs for trout at lOoe; and the 169 hrs and 157 hrs
for carp at SoC (Nouws et ai, 1992) .
T 112 is a parameter derived from volume of distribution and c learanc e (TIn '" Vd....,.lCll •
In) and. assu ming that volume is constant. is an indicato r of the rate of elimination. It is
estimated that a 1°C change in temperature alte rs the metabolic rate of fis h by 100/0 (Elli s
et at. 1978). Becau se excretio n rate is affect ed by meta bolism. it too is temperature
dependent (Ingebrigts en, 1991). This theo ry is supported in :an experiment by Bjorklund
and Bylund (19 90) in which. elimin ation half-lives and beta value s were measured for
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Rainbow trout held at three different temperatur es , A long half-life (TIn ), with the
associa ted small beta, is indicati ve of an extended elimination time . A short half-life, with
the associated large beta, is indicati ve of rapid elimination. Trout held at temperatures of
5°C, lOoC and 16°C had half-live s of 213, 146 and 115.2 hours with betas of 0.078,
0.114 and 0.143 respectivel y. The short half-life values and large betas at high
temp eratures support the theo ry that elimination rates increas e with increasing
temperature. In another experiment by the same group the T tr.r: value for Atlanti c salmon
held at l'::: ISoC was 127.2 hours and for Rainbow trout held at ~18°C was 48 hrs. Salte
and Llestol (1983) calculated betas of 0.069 and 0.056 for rainbow trout held at 9.6°C
and 7.5°C respectiv ely. Nouws et at ( 1992) obtained half-life valu es in tro ut of ISOhrs at
lOoC and 76 Ius at 19°C. In carp they obtained T 112 values at SoC of 169 hts and IS7 hts
and values at 20°C of 52 hrs and 79 hrs.
The PO elimination half-life of 184 hrs in this study for fish held a 10°C is longer than
that of 16 hours obtaine d by Uno et al (1992) for Amago salmon held at 15°C and
shorter than that of 3 13 hrs obtained by Haug (1994) for charr held at 6.7°C . They are in
the same order of magnitude found in trout at lOoC of 146 hrs (Bjorklu nd and Bylund,
1990) and 150 hrs (No uws et al , 1992) , This fits in well with the theo ry of temperature
effect on elimination half-life.
Method of admin istration affects elimination in a pattern corre lated to drug concentration
levels. Administra tion resulting in high tissue concentrations (IV , IP or 1M) result in
rapid elimination. Conversel y, methods of administration resultin g in low tissue
concentrati ons (PO) result in prolonged elimination periods (Sal te and Llestol, 1983;
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Jacobsen, 1989). This is we ll corroboratcd in this experiment in that thc T\l2 for OTC in
cod was found to be 154 hrs for IP administrati on and 184 hrs for PO admin istration
despite a higher Cma..: of 140 ppm for IP than of l.04 ppm for PO. In trout. Bjor klund and
Bylund (1991) obtained an IV T 1I2 of 60.3 hrs (Cmaxof 113 ppm) and a PO T II 2 of74.9
hrs Ce-. of2 ppm). They noted that IV and IP administra tion had similar T U2 values for
OTC. however. no numbers were given. Gronde l et al (1989) obtained T I/2 values for IV
administra tion of 895 hrs (Caw. 753) and for 1M admin istra tion of 94.7 hrs (Cm.x56.9)
for trout held at 12°C. It shoul d be noted that at low concentrations (as found with PO
administration) elimination curves reach an asymptote therefo re the depletion period (and
corresponding withdrawal times) can be very long (Burlca.et al, 1997).
Because T1/2 is affected by concentration, dose levels wou ld also affect elimina tion time.
Rainbow trout with an OT C IV dose of 50 mg (Uno et al, 1997), 20 mg (Bjor klund and
Bylund. 1991) and 5 mg (B lack et ai, 1991) rendered T I/2 values of 52 hrs, 60 .3 hrs and
81.5 hrs respectively. The T I/2 values of 154.2 hrs after an IP dose of 132.8 mg arC! kg
fish and 184 hrs after a PO dose of 134.5 mg OTC! kg fish found in this experi ment are
relatively high. This is believed to be caused by an overestimati on of T 1I2 result ing from
the rise in the termi nal porti on of the IP and PO curve . Thi s overestimation will impact
on subsequent discussions on T1/2
Species differences were foun d when a general comparison of literature T 112 data was
made . Contributing facto rs to this may be differences in: metabol ic rates, fat and protein
content and musc le perfus ion . No uwes et af (1992) conducted an experiment with carp
(whiteflesh). trout (redflesh) and eel (high fat! protein) held at similar temperatures . They
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obtain ed T Ill values for IV admin istratio n of 76 hrs for trout and 52 hrs for carp. 1M
administratio n resulted in a T I!l in eel of 196 hrs , in trout of 150 hrs and in carp of79 hrs .
The T Ill of 154.2 hrs obtained for cod after IP administratio n in this experiment is hig h
compared to an IP Ti n of36 hrs in carp . Once again the high Till from this experi ment
may be a result of the rise in the termina l portion of the absorption curve . The role ,
however. of physiological differe nces on T112 is evident overall and sup ports the premise
that cross species pharmacokinetic assumptions should be made with caution.
In fresh water . T il" can be prol onged compared to the T Ill in saltwater. This is beca use
catio ns in saltwat er che late with O'I'C and so reduce the amount s of O'I'C absorbed and
reabsorbed from the GI tract (McSwain, 1992; Burka et aI , 1997) . This trend is
corroborated by T in literature values . In salt water. salmon had a T V2 of 50A hrs (Elema
et aI, 1996), in brackish water Rainbow trout a Ti ll of40 .8 hrs and in fresh water a T ill of
115.2 (Bjorklund and Bylund, 1990) to 74.9 brs (Bjorklu nd and Bylund. 1991). This
trend is not supported by the findings of U no et aJ(1992). They fou nd a T in of 16 hrs for
freshwat er Amago salmon, 23. 2 hrs for freshwater trout and 28 hrs for saltwater
Yellowtail. Specie s differences may have masked the effect of salinity in that experiment.
It should be noted tha t elimina tion of drugs in freshwater fish.can occur through th.eurine
therefo re excretion would be affected by the glomerular filtration rate (Ingebrigtsen et al,
1985; Guarino. 1988. 199 1). The impact of this effect on elimination rate compari sons is
unknown .
Uno (1996) found Till values in healthy Ayu of 53. I hrs and in infected Ayu of63.2 hrs.
These two values were considered "similar " by the author however no statistical analysis
was co nducted . Bruno (1989) found OTC res iduals 8 weeks post admi nistra tion of 3.7
ppm in the mu scle of furunculosis infected fish and of 1.3 ppm in healthy fish. Diseases
negatively affect the physiology of fish and thet"efore may impact on its ability to
eliminate drugs . Little work could be found in the litc:ruure on the pharm aco kinetics of
drugs in sick-fish.
Another factor whic h may play a role in prolonged Ttn values is plasma protein binding
and the acca mulat lon of drugs in pronep hros. bone and scale . Duri ng elimination, free
drug is removed from the reservoir and prot ein bound drug is then released and available
for diffusion through the syste m. Reversibl e bindin g means that the liver and other
extravascular co mpart ments may serve as pool s of active drug (Grondel et aI, 1987,
Grendel et aI. 1989). High levels o f bound drug will extend the time the drug is availab le
within the biological system (McS wain. 1992) . Values of 55% (Bjo rkhmd and Bylund,
199 1) and 51.1% (U no et aI, 1997) have been found for serum protein binding in trout.
No evaluation of serum protein binding was made for cod in thi s experiment.
Due to the unusual shape of the PO curve, clearance time of OT C from the serum could
not be calculated by PCNONLIN. An estimate ofclearancc was calculated using the T tn
value. This was done by multip lying the calculated half-life by a factor of five . It is
estimated that after five half·l ives ...3% of the maximum co nce ntra tion of OTC will
remai n (Baggon. 1988. Black-etal. 199 1).
SX t8 4 hours -920 hrs
- 38 .3 days for OTe to clear from seru m at lOoe
..
The clearance time from the musc le of cod was then calculated using affini ty ratios.
Affini ty ratio s are the ratio of the concentrati on of aTC in an organ (in this case the
muscle) relative to serum concentrations over the elimination period. Affi nity ratios for
muscle in trout and salmon were obtained from the literature. Blac k (1991) calcula ted an
affinity ratio of 2.1 for muscle at lOoe, Nouws et aJ (1992) of 0 .65 at w oe, Gre ndel et ai
(1987) ofl .25 at 312 hrs, and Rogstad et al (1991) of 1.8 at 336 hrs. The average of these
muscle ; serum affin ity ratios is 1.45. The estimated clearance time from the serum is then
multiplied by the muscle affinity ratio to give an estimate of clearance time from the
muscle.
1.45 X 38.3 = 55. 5 days
The estima ted clearance time for OTC from the muscle of cod at lOoe is 55.5 days . This
method of predicti ng clearan ce time is considered robust .
Anothe r calculation of imponance in pharmacokinetics is bioavailability (F) .
Bioavailabil ity is a measure of the extent to which a drug, administered at a particular
dosage , enters an organisms systemic circulation in activ e form (Baggott, 1988).
Bioa vai lability affects the pharmacokinetics of a drug. The route of admin istrati on has a
major affect on bioavailabiiity. Drugs admin istered intravenously (lV) are considered to
be 100% bioavai lable . Intramu scular (IM) and intraperitoneal ly (ll') administered drugs,
because they are not injected directly into the bloodstr eam, express less than com plete
systemic availability . Grondel et al (1989) found values for 1M administration of O'TC of
86% in African catfish, 85% in trout and 80"/0 in carp . No values could be found for IP
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bioavailability. The 1M:and IP methods of administration are expensive and impract ical
for large numbers of fish but can be effect ive when treating smaller num ber s of valuable
fish such as broodstock. Drug s administered orally , because they pass through the
digestive tract before entering the circulation system, are considered to have the lowest
bioavailabil ity. Despite this, it is the most practical method of administering antibi otic s to
large number s of fish .
There are two measures of bioavailability : absolute and relative . Absolut e bioa vailability
refers to the abso rption of a drug relati ve to intravenou s (IV) inject ion; relati ve
bioavailability re fers to the absorp tion of a drug relati ve to intramu scular (IM) or
intraperitoneal (IP ) injection. Relative bioa vailability of oral vs IP inject ion of OT e in
this experiment was calculated using the equation AUc;.oxoosel AUCpXDose X 100
where AUCp.,is the area under the concentration time curve for PO administra tion and
AUC;p the area under the co ncentration time curve for fP ad min istratio n. The relative
bioavailab iliry was calculated to be 0.8%. Absolute bioavailability would be lower.
Published literature shows tha t oral bioavailabi lity of O'I 'C is co ns iste ntly low with values
in Atlantic salmon ranging from 1.94% (Elema et ai, 1996) to 1.5% and 7.4%
(MacSwain, 1992) . In trout, va lues of 8% (Crevedi et ai, 1987), 5.6% (Bjorklund and
Bylund, 1991), 2.6% (Rogstad et ai, 1991), 1.25% (Nouws et ai , 1992) and 0.6% (U no et
ai, 1992) have been found . In carp bioavailabiliries of 0.6% (Grond el et ai, 1987) and
0.38% (No uws et ai, 1992) have been found .
Low oral bioavailab iliry may be the result of several factors. First Pass Effect describe s
the phenomenon by which all compou nds absorbed from the intestine enter the blood
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flow of the hepatic portal system and are transported directly to the liver. Any orally
administered compo und is filtered through the liver first and, if the re is a substantial First
Pass Effect onJy a small fraction may reach systemic blood circulation in unchanged
form. Compounds, such as tetracycli nes, which are metabolized by or have an affinity for
the liver will be relatively unavai lable. (Grondel et aI, 1987, McSwain, 1992). The
additional impact oftbis effect in species, such as cod.which undergo seasonal variations
in hepatic metabolism may bear further study.
An increase in salinity will also reduce the bioavai lability of some ora lly administered
drugs (Lunestad and Goksoyr, 1990; Burica et al, 1997). In the case of OTC, chelation
with di- and tri-vale nt cations occurs. This results in an alteration ofthe molecular charge
ofOTC and a subsequent reduction in its ability to cross lipid rich biologica l membranes .
The intestine of seawate r-adapted fish (which drink actively for osmoregulation) contains
a high proportion of cations, particu larly Ca++ and Mg++ . Patterns for salinity effects
can be found when examining the extremes of literature bioavai lability data . Values have
been reported in saltwa ter of 0.8% in cod and 1.94% (£lema et al, 1996) and 2%
(McSwain, 1992) in Atlantic salmon . In freshwater, values as high as 9.8% in Ayu (Uno ,
1996) to 5.6% (Bjor klund and Bylu nd,1991) and 8% (Cravedi et ai, 1987) in trout were
found. These numbers support the theory that saltwater reduces bioava ilabi lity. There are,
however, numbers which range widely in between with values as high as of 7.4% in
saltwater salmon (McSwain, 1992) and as low as 1.25% (Nouws et aI, 1992) and 2.6%
(Rogstad et al, 1991) in freshwater phase trout . These large variations may be due to
differences in experimental design and support the premise that some standard ization of
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methodolo gies used in phannacokinetic experim entation is required . Variations in the
results of phanna cokineti c experiments are discussed further in Experiment 2.
The low F of 0.8% found in thi s experiment is belie ved to have resulted from chelation of
a Te with cations in the herring paste and with cations in excess saltwater in the stomach
which occurred as a result ofIow feeding levels.
Another factor which affects the bioavailabili ty of drug s is the pH of the environm ent.
Typicall y, the pH is higher in saltwate r than in freshwater and becaus e weak: acids are
relat ively more ionized and less lipid soluble at higher pHs their bioavai lability is
affected. Burke et a l (1997) found that the bioavaila bility of quinilones was reduced in
seawater. The same may be tru e for OTe (a weak:acid) though the effect may be small
and difficu lt to quantify give n the high variabili ty found in this type ofdat a.
Dose levels were found to affect bioavailability in Oxolinic Acid wi th bicav ailabiliries
being higher at lower doses. Bjorklu nd and Bylund (1991) did not find a dose effect for
OTe in their experim ent.
Finally, health status may affect bioavailabili ty . BA in healthy Ayu was found to be 9.3%
and in infected Ayu was 3.8%. This may be the result of reduced absorptio n due to
damage to the digestive tra ct by the bacteri a or toxin (Uno, 1996)
50
4.1.1 Co ncl usioo: Pb armacokin etics
In this experiment baseline pharmacokinetic data was generated for aTC in cod and used
to predict clearance time from the body . It was found that the pattern of absorption for IP
administered OTC. with a doub le absorptive peak, varied from that found in the
literature. This may have resulted from precipitation in the injectab le solution . A rise in
the terminal portion of the PO curve is believed to have resulted from the delayed
absorption and reabsorption of OTC from the GI tract as a result of high levels of
mucous. Variations in enterohepatic recirculation may have contributed to the rise in the
terminal portion of both the IP and PO curves. The role of variations in hepatic
metabolism and feed patterns on the pharmacokinetic behaviour of OTC in cod bears
further investigation.
The maximum serum concentration (Crnu) of OTC was higher for IP administration
(14 0.8 ppm) than PO administration (1.04 ppm). In the literature, inject ed drugs are
consistentl y found to have a higher Cmax than orally administered drugs . The time to
maximum serum concentration (T-J for IP administered OTC at 18 hrs was higher than
the PO Cm.x at 6 hrs. This may have resulted from the doub le peak in the IP absorption
curve. Literature values indicate the injected drugs nonnall y have a snorter T=>: than
orally administered drugs . These results indicate that method of delivery has a significant
impact on efficiency of absorptio n ofa drug, with inject ion delivery being more efficient
than oral deli very. A literature search indicated that serum concentrations of a drug are
also affected by temperatur e. species differences, salinity and health statu s.
The eliminat ion half- life (T lI:l) was calcu lated to be 154.2 hrs for IP and 184 hrs for PO
administered OTe. The rise in the terminal portion of the concentration time curves may
have resulted in an overestimation of half-life however they are in order with those found
in the literature. In future experiments, longer sampling periods will be used so as to
ensure that absorption is complete. A literature search shows that T lI:l is affected by
temperature, method of administration, serum concentration, fat content. vascu larization,
salinity , health status and plasma protein binding.
Bioavailability is affected by method of administration with injected drugs having a
higher bioavaila blliry than orally delivered drugs. The low bioavai labiliry of 0.8% for
OTe administered orally to cod was consistent with values found in the literature. Given
the large number of fish to be treated under farm conditions , oral delivery is still
cons idered the most practical method for delivery of antibiotics. Oral bioavai labil ity is
also affected by salinity, food composit ion, drug formu lation and pH. Hepatic
metabolis m may affect bioavailablity.
From this experime nt clearance time for OTe in cod held at lOoe was estimated to be
38.3 days from the serum and 55.5 days from the muscle. These numbers will be
compared wit h the actual clearance numbers generated in experiment 2.
4.2 Temperature
In this experiment the absorption, distribution and elimination cfO'I'C was mapped in the
blood , gonad , musc le and liver of cod over a 101 day period at two temperatures. In twO
of the control liver samples there were detectabl e levels of OTe at day 5 and day 20 .
Th ese residual s are believed to have resulte d from cross contamination of samples at
point of analysis. They are not believed to be due to inadvertent administration of OTe as
that would have resulted in residuals in all organs . Neither are they bel ieved to be a result
of prior treatment as there wasa 10 month period from date of last antibiotic treatment to
commencement of experiment.
As described in the phanna cokinetic experiment, T....,.is the time at which a drug reaches
its maxi mum concentration. For serum, Tmax is indicative of how quickly the drug is
digest ed out of the feed and absorbed into the blood. In the organs, Tmax represents the
distributi on time from blood to the organs . The maximum concentration of a drug (Cma.:)
is indicati ve of two distinct features: the amount of drug avai lable for absorption by the
blood and distributi on of the drug to the body. The first factor is affected by
bicavailebility, the second by affinity. Affinity , in tum, is affected by vascularization, the
presence of specific binding sites, protein content and fat content (lngebri gtsen,1991).
Overall . temperature is the major environmental variable affectin g absorption,
distribution and elimination in poikilotherms .
As with the pharmacokinetic experiment, scientific accommodation must be made in the
upcomin g discussion for environmental and species differ ence s when comparing result s
among experiments.
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In this experime nt, a gonadal e-.: of I ppm was found at a T....,.of 12 hrs. Black et al
(1991) found concentrations of 4.92 ppm of OTe in the gonads of trout after an IV
administration of 5 mg OTCI kg fish. Ingebrigtsen (19g5), in a whole body
autoradiography experiment with trout, showed relatively high levels of OTe in the
gonads . For this reason, it was anticipated that gonadal aTe levels wou ld be present at
levels above the LoD of 3 ppm. They were not. One possible explanation is that the cod
had just completed spawning and therefore no energy was being directed towards
production of the gonads (Scon and Scott, 1988). The reduced vascularization, lipid and
protein content of undeveloped gonads may have resulted in reduced conce ntrations of
O'I'C in that organ. From this experiment the only conclus ion that can be drawn about
residual OTe in the gonads of cod is that they did not exceed 3 ppm when administered
immed iately post spawning . It is anticipated that any aTe present below 3 ppm on
Sample day 1 would have had sufficient time to clear to the legal limit of0.1 ppm over
the 101 day elimination period . Refinemen t of the HPLC procedure for gonadal material
to LoDs approaching 0.1 ppm would allow the confirmation of this in a subsequent
experiment.
In serum, the shape of the curve shows a rise to a single peak at day 5 followed by rapid
elimination to day 20 with slow, steady elimi nation thereafter. This pattern ofabsorption,
distribution and elimination is simi lar to that found by Bjorklund and By lund (1991),
Grendel et aJ (1987) and Uno et aJ (1997). The maximum concentration of 1.3 ppm at
day 5 is in order with the e...u of 1.7 ppm at 72 hrs in trout (Rogstad et ai, 1991)
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Serum c....... from the phannacokinetic experiment was 1.04 ppm after a single, oral dose
of 134 rng OTC! kg fish. In this experi ment e..-was 1.S ppm after a 10 day oral dose of
120 mg OTC! day. Given the multiple dosing ofOTC it was anticipated that Cmax would
be higher. In the pharmacokinet ic experiment, a distinct layer of OTC, sandwiched
between a smal l amount of herring paste, was administer ed directly to the cod via
syringe. This resulted in direct contact of the GI tract with the OTC . In this experiment
the OTC was administered in the body cavity of smelt. Administration of the requis ite
amount of OTC was based on the observatio n that cod were consumi ng, on average , two
smelt per feedin g. Individual variatio ns in feeding levels along with variability in
digest ion time, gastric emptying and the chelation of OTC with catio ns in both the body
of the smelt and seawater in the stomach would have reduced the bioavailability ofOTC
in this experi ment. In a disease outbreak on a farm, the compromised physiological status
of sick fish and their subseq uent reduced appetite would increase this variability even
The inefficiency of oral adm inistratio n as a means of delivering OTC is emphas ized in a
study by Bjorklund and Bylund (1991) . Trout held in the labora tory at 16°C were
admi nistered a single oral dose of 7S mg OTC! kg fish and achieved a maxim um muscle
concentration of2.9 ppm at sample day 2 . In a field trial with rainbo w trout held atl8°C,
OTC was administered for 10 days at 100 mg OTC! kg fish! day. Musc le concentrations
ofOTC were at 0.6 ppm on the last day ofadmini stiation and were less than 0.05 ppm at
samp le day 7. These levels are significantly lower than those achieved in the laboratory
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study . Despite the dubious efficacy of OTC administered in the feed, it is the only
practical method presently avai lable for treati ng large numbers offish.
In muscle, the shape of the curve shows a rise to a single peak followed by rapid
elimination to day 20 with slow, steady elimination thereafter. The pattern of abso rption,
distribution and elimination is simi lar to that found by Rogstad et af (1991) and Uno et al
(1997). Taw< was at day 10 with a c...... of0.76 ppm. The de layed Tm&l[in muscle relat ive
to the serum (day S) is reflect ive of the time required for O'I 'C to be distributed from the
blood to the organs and tissu es. The same pattern was found by Rogstad et al (1991) with
a maximum in the serum at 72 hrs and a subsequent maximum in the muscle at 96 hrs .
Bjorklund and Bylund (1990) had a maxi mum in the serum at 12 hrs with a subsequen t
maximum in the muscle at day 4.
In the liver, the shape of the curve shows a rise to a single peak, rapid elimination to a
plateau between day 20 and day 41, another period of rap id elimination to day 61 with
slow, steady elimination thereafter. This pattern is indicative of enterohepatic
recirculation and is similar to the biphasic absorption found in the liver of trout (Rogstad
et af, 1991; Uno et a/ ,1997) and Amago salmon (lJno, 1992) .
Bjorklund and Bylund (1990) found tempera ture effects on hepatobiliary funct ion .
Rainbow trout held at SoC had a maximum of20 ppm at day 9, a plateau in eliminatio n to
day 20 and slow steady eliminatio n thereaft er. Trout held at 16°C had a single absorptive
peak of 24 .1 ppm at day 2 with relatively rapid elimination thereafter. This indica tes that
lower temperatur es magnify the effect of enterohepatic recirculatio n and resu lt in
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prolonged ret ention of aTe in the liver and bod y syste m as a whole. Variations in
hepatic metabolism might affect a dNgs abso rpti on and distribution especially in species
which undergo seuonal vari ations in feeding (B runo , 1989; Bjorklund and Bylund, 199 1;
Ingebrigtsen, 1991; McS wai n. 1992). Affinity ofthe liver for OT C may also co ntribute to
an extended elimination period (Whittaker and Eal es, 1993; 1ngebr1gtsen.198 5;).
These effects would significantly aff ect farm ed cod as they go throu gh profoun d seasonal
changes in feed ing levels and hepatic metabolism . Cod feed minimally duri ng the winter
and thr ough th e spring spawni ng eve nt. En ergy durin g this perio d is deriv ed from the
liver . In the fall, energy is directed towards liver prod uction . In cod the effe ct of low
temp erature and period s of nonfeed ing on enterohepatic recircu lat ion are co nfounding
effects as th ey occur simultaneously. How ever , acti ng independently or in assoc iat ion.
they wi ll affe ct the abso rptio n, distribution and elimi nation of OTC. At present, the high
risk period of disease is Ju ly to Sept ember. As hatchery prod uctio n repl aces wild suppl y
and cul ture activi ty becomes more int ensiv e th e occurrence of disease may ina-ease and
occur over a wider period throughout the year . Th e possibility that OT e. admi nistrated at
different times of the year , will display differe nt phannaookinetic behaviour shou ld be
investi g ated .
Liver T-..: was at day 10 with a c....... of 42 ppm . Thi s is the same order of magnitude
found in tro ut by Rogstad eIQ / ( I99 I ) with a maxi mum of 44 .7 ppm at n hrs and Black
ela/(1991) with a maximum of SOA ppm at 2 Ms.
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In this experiment, senun Tmax occurred at day 5 with the muscle and liver T......, occurring
at day 10. This differs somewhat from Bjorkl und and Bylund (1990) and Rogsta d et a1
( 1991) in that their maxim a were achieved simultaneously in the serum and liver first
with a subsequent maximu m in the muscle . Orall y administered drugs are absorbed out of
the digestive tract and filtered through the liver (First Pass Effect) before they reach
syste mic circulation. This could result in a concurre nt rise in OTC leve ls in the liver and
blood. Distribution to the organs would be delayed relative to this.
The highest conce ntration ofOTC was foun d in the liver at 42 ppm followed by serum at
1.3 ppm and muscle at 0.76 ppm. Given that all oral ly admi nistered drugs are carried by
the blood to the liver before they enter systemic circulat ion. a high accu mulation of OTC
in the liver was expected . There is variabi lity in the data in the literature for whether
OTC has a grea ter affinity for blood or muscle. In studies by Ingebri gts en (1985) and
Haug (1992) the orde r of maxi mum concentration was liver, blood and then muscle. In
studies by Rogstad et al (199 1) and Uno et 01 (1992 ) the order of maxi mum concentratio n
was liver. muscle, and then blood . Musc le and blood appear to have an almost equal
affin ity for OTC. This affinity appears to be affecte d by temperature. In an experiment by
Bjo rklund and Bylund (1990) the highest concentra tions ofOTC at 10°C and 5°C were
achieved in the liver, serum and then muscle. At 16°C the order was liver, muscle and
the n serum. A variety of facto rs such as prot ein binding, vascularization of tissues and
organs, and differing metabo lic Tates may acco unt for this
MI C is the minimum concentratio n of an antib iotic required to inhibit bacterial growth. In
order to achieve a therapeutic effect the antibiotic must accu mulate in organs and tissues
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at concentrations above the t<.1lC of the target pathogen for a period of ""5 days. Giles
(1992) determined that the t<.1lC90 for Vibrio spp. was 0 .5 ppm at 10°C. In this
experimen t, therapeutic levels were achieved in the serum fro m day 1 to day 10, in the
muscle from day 5 to day 10 and in the liver from day I today61 .
Data from this experime nt were subjected to statistical analysis to determine if there was
an effect by temperatur e or sample day on the absorption, distribution and elimi nation of
OTC in the organs and tissues of cod . The variability in the data for individ ual fish in this
experime nt resulted in relatively high standard errors (SE). SE in the serum data ranged
from 0.2 ppm at a mean of 1.3 ppm to 0.2 ppm at a mean of 0.8 ppm . The SE in the
muscle data ranged from 0.23 ppm at a mean of 0.76 ppm to 0.01 ppm at a mean of 0.02
ppm and those in the liver data ranged from 6 ppm at a mean of 42 ppm to 3 ppm at a
mean of 17 ppm. The literatu re was reviewed to determine how these data compare to
other results. It was found that Bjorklund et oj (1991), Jacobsen et at (1989), McCracken
et al (1976), and Uno et at (1992) conducted limited statistical analyses on their data.
Others restricted their statistical analysis to measuring standard deviation, standard erro r
and variance , and these tended to be high as welL Craved i et al (199 1) used a student t
test and had standard deviat ions in the liver ranging from 299 ppm at a mean of 404 ppm
to 14 ppm at a mean of29 ppm with a sample size of6. Grondel et al (1987) had standard
deviations in the serum ranging from 10.9 ppm at a mean of 56.8 ppm to 0.1 ppm at a
mean of 0.34 ppm with a sample size of5 . Strasdine and McBride (19 79) had standard
errors in the serum ranging from 0.11 ppm at a mean of 0.33 ppm to 0.42 ppm at a mean
of 0.8 ppm with a sample size of S. Many factors affect the variability found in the data
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for this type of experiment. Bjorklund and Bylund (1990) found that variations in
absorption and elimination were more pronounced at low t emperatures (3.2:1::1.8 ppm at
SoC) than at high temperatures (2.1:1:0.5ppm at 16OC). Thi s resulted in high standard
errors at low temperatures. Sample size in that experiment was five. Other conuibuting
factors include low sample numbe rs, large variations in the physiological state of the
experimental animal , low bicavailability, variable feed uptak e, variations in gastric
emptying time. metabolic rate fluctuations and variability in the method of analysis. In
this experiment a source of vari ability was the low feed level s of the cod throughout the
administration phase and its subsequent affect on delivery of the drug . Administration of
O'I'C at the requisite dose was based on the observation that the cod would consume, on
average, two smelt per feeding. There was individual variation from day to day in this
pattern.
A two factor analysis of variance was run on the Gompert s transformed data and no
temperature effect could be detected for the absorption and d istribution of O'I 'C in serum,
muscle and liver at the temperature regime used. This is believed to be a result of the fact
that Cmax and T-.. were achieved before there was a signi ficant difference in
temperatures between the two temperature groups. Fluctu ations in temperature contro l
resulted in a o.soe difference in the temperature groups at day IO when there should have
been a l.OOe difference . As a result, the two temperature groups were sampled as a
common temperature group to day 10. Absorption to the blood at day S and distributi on
to the muscle and liver at day 10 had occurred by this time and so no temperature effect
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could be detected. No temperature effect was detected for elimination from the serum,
muscle and liver at the tempera ture regimes used .
There was an effect on concentrations ofOTe by sample day. In serum, the signi ficant
differences were between O'T'C levels up to and including day 10 (absorption and
distributio n phase) and levels including and after day 20 (distributi on and elimination
phase). In muscle , the signifi cant differen ces were between O'I'C levels up to and
including day 10 (absorption! distributi on phase) and levels including and after day 20
(distribut ion! elimination phas e) . In liver, the significant differenc es were between O'TC
levels up to and including day 41 (absorption and distribution phase) and in levels
including and after day 6 1 (elimination phase).
The elimination rime of a Te from the serum, muscle and liver varied. Levels of O'I 'C in
the serum at day to were above 0.1 ppm (legal limit) in the commo nly sampled
temperature gro up. At day 20 O'I 'C residuals had been eliminated completely from the
lOoe group and were still at the legal limit of 0. 1 ppm in the 2°C group . At this point
there was a l oe temperature diffe rence between the two temperature group s. At day 41
elimination was complete in the 2°C group . As with the absorption and distributi on
phase, most of the aTe had been eliminated from the serum before there was a
significant temperatur e difference betwe en the two temperature groups. As a result no
temperature effect was detected .
Levels of O'I'C in the musc le at day 20 were above 0.1 ppm (legal limit) in both
temperature groups . At day 41, O'I 'C residuals in both temperatur e groups were
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det ectable but below the legal limit . At this po int there was a J .!?C tempe ratu re
differ ence betwee n the two grou ps. At day 61 there were no detectable residuals in either
gro up. There was no tempera tur e effect detected.
Leve ls ofOT C in the liver at day 20 were well abov e the legal limit of 0.1 ppm in both
temp erature gro ups. At this point there was a l. O°C temperature difference between the
two group s. There was a plateau in elimination in both groups between day 20 and day 4 1
with a tempe rature differential ofJ .9°C at day 4 l. At day 61 the 10°C group was over the
legal limit of 0. 1 ppm and there were no detectable residual s in the 2°C group . Day 61
marks the beginning of the eliminat ion phase in both groups and at this point there was a
6°C differe nce in temperatu re. At day 101 there were residuals in the 2°e gro up and none
in lOoC gro up. There was a differ ence between the two gro ups from day 20 to day 10 1
with the const ant temperatur e gro up eliminating more rapidly than the decreasing
temperature gro up. This difference was not found to be statistically significant. It is
believed that the variability within the sample groups masked the difference between the
temperature gro ups
There is, however, evidence in the literature of temperature effects on absorption,
distribut ion and eliminat ion o f OTC. In the experiment on trout by Bjorklund and By lund
(1990) , serum T......was achieved at I. 12 and 24 brs for fish held at 16°C. 10°C and SoC
respecti vely. Thi s indicates an obvious temperature effect with absorption occu rring more
rapidly at higher temperatu res . T..- in the muscle occu rred at day 2. 4 and 9 at 16°C,
10°C and SoC. As with absorption, distribut ion occurr ed more rapidly at higher
tempe rature s. Distribution of the drug from blood to muscle was determined to be slower
and mar c temperature dependcnt than absorption. T... in the liver was achicved at day 2.
12 hrs and day 9 at 160C, IOOCand 50C rcspecrivcly. There is a temperature effect. • with
OT C being disaibuted to the liver more efficiently at IO"C than at 16"C. An eval uatio n of
maximum co ncentrations sho wed that they were higher at 10"C as well. e.u in thc
serum was 2.1. 5.3 and 3.2 ppm. in muscle it was 2.9. 4 .0 and 2.6 ppm and in liver it was
24.1. 45.8 and 20 ppm at 16"C. 1O"C and 5"C respective ly. Thi s indi cat es that abso rptio n
and distribution are most efficient at IO"C . Lower maxima at SoC may be attri butabl e to
lowe r absorption of oral ly administered drugs from the intes tine as a result of red uced
membran e fluidity (ln gebrigtse n, 1991). Lower peaks at 16°C may be due to highe r
metabolic and elim inatio n rates . The fact that c....... occurs at IO"C may be a reflect ion of
the fact that this is the optimal temperature for tro ut .
Bjo rkl und and Bylund (1990 ) also showed a temperature effect on elimination of OT C.
Elimination fro m thc serum occurred by day 20 , 30 and 40 at 16"C. IO"C and SOC
respectively. Elimination from the mu sclc occurred by day 32 in the 16°C and 100C
group and by day 40 at SOC. Elimination from th e liver occurred by da y 32. 42 and 40 at
16°C. 1000C and SoC respectively. Elimination of OTe from the organs and tissu es was
consist ently mo st rapid at 16°C. An anomaly was that OT C eliminated from the liver
more rapidly at SoC than IO"C. No expl anati on could be found for that effect..
As was men tioned previously, ad ministration ofOTC in the feed un der fann co ndit ions is
inefficient relative to laboratory conditio ns and results in low er maxim um co ncentrations
in the t issu es and organs . This poo r uptake would resu lt in a subsequent reduct ion in
clearance time as there would be significantly les s orc to eliminat e from the body . In
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add ition to this, fish. in cage s are able to swim freely. Swimming causes increases in
cardiac volume and a decrease in systemic resistance (Evans. 1993) and would serve to
increas e the rate at which OTC is eliminat ed. The experiment by Bjorklund and Bylund
(1990) emphasizes this point . Trout held in the laboratory at IO"C and admin istered 7S
mg OTC! kg fish in a single oral dose had a 32 day elimination time from the muscle;
trout held in cages at 18°C and fed 100 mg OTCI kg fish for 10 days had less than O.oS
ppm OTe in the musc le at day 7.
The lack of a temperature effect in the present experimen t is largely attributable to the
fact that there was not enough of a temperature difference between the two groups in the
initial phas es of the experiment . However , Hazel et ai, 1979 (in Inge brigtsen, 1991) found
higher hepatic metabo lic activity (ph ase I) for cold acclimated trout than warm
accl imated trout when measured at a standard incubat ion temperature. The possibility that
acclimatio n plays a role in the absorption, distribution and elimination of compound s in
the body of cold water fish should be considered in future experiments . The temperatur e
regime used in this experime nt mimicked that of the farm and so was appropriate for the
question at hand.
The pharma cokinetic experi ment (Experi ment 1) resulted in a predicted clearance time
for OT C from the serum of 38.3 days. The actual clearance time was between day 20 and
day 4 1. Similarly, the pharma cokinetic experiment predicted a clearan ce time for OT C
from the muscle ofSS .S days. The aetual time was between day 41 and day 61.
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4.2.1 Co ncl usion: Tem pera ture
In this experiment we evaluated the effect of ambient water temperatures on the
absorption, distribution and elimination ofOTC from the serum, flesh., liver and gonad of
cod . We also determined the affinity of tissues and organs forOTC.
The results from this experiment indicate that the liver hasthe highest affinity for OTC
with serum and muscle showing equal but lower affinity . A lack of residuals in the gonad
may be a result of the reproductive phase of the fish used in this experiment.
Consid eration should be given to the hypothesis that there may be seasonal variations in
gonadal levels of OTC.
There was no temperature effect on the absorption, distribution and eliminati on of OTC
in cod at a temperature regime rnimiclcing that found on the farm. This may be a result of
insufficient temperature differentia ls during the initial sampling period . While these
results are sufficient for the original question of clearance under farmed condit ions,
future experiments should see larger temperature differences between the experimental
groups . The role of acclimation of cold water fish to low temperatures on the clearance
ofOTC from tissues and organs should also be considered.
Statistical analyses showed an effect by day on concentrations of OTC . The significant
differences lay between concentrations in the absorption and distribution phases and
concentrations in the elimination phase for serum. muscle and liver.
Minimum Inhibition Concentrations for Vibrio spp . were achieved in the serum. musc le
and liver .
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Improvements in fub.Jre methodo logy should see larger sam ple sizes and, as cod is
intended as a skin-o n product, skin should be included in the anal ysis.
From this experiment it was determined that OTC level s in the muscle and SCfUII1 (both
temperature groups) fell below 0.1 ppm (legal limi t) by Day 61 and 41 respecti vely.
Tbere were no detectable levels of OTC in the gonad after Day 1. This indicat es that the
regulatory guide lines o f an SO.day clearance time for OTC from the flesh offish held at
or above l00C are accep tab le under Newfoundl and fann conditio ns. The 80 day limit also
appears to be acceptable for cod held at or belo w 10"C. Predictions fro m the
pharmacokinetic experiment for clearance from the serum and muscle were well
corrobo rated in the elimination experiment.
Concentratio ns of OTC in the liver (both temperature grou ps) were high and are not
believed to have fallen to 0.1 ppm by the end of the experi mental period. Should industry
decide to harvest the liven of cod, extended clearance periods shou ld be considered.
..
5. General Co nclusio n
At present there are three antibiotics (OTCMHCL, sulphadimethoxine: onnetoprim and
sulphadiazine: trimethoprim) licensed for use in aquaculture in Canada . Extended period s
of use of one often results in the development of resistant strains of bact eria and
necessitat es a change to an alternat e antibioti c. This results in a cycle of use thr ough the
three available antibiotics . Given co ncerns over the use of antib iotics in food animal s it is
unlikely that new antibiot ics will be licensed and so it is anticipated that there will always
be a dependenc e on the use of OT e in aquaculture. Physiological and environmental
differences encountered by poikilotherms introduces high variability in cross spec ies
assumptions on the use of antibioti cs. As a result it is critical that a standardized database
be established for the pharmacokinetics of QT e in cod and other marine species so as to
set acceptabl e treatment regimes and clearance times for the industry .
Overall resear ch should focus on determining the effect of seasonal variations in hepat ic
metab olism and feeding levels on the pharm acokinetics of drugs in cod. Acclimation to
optimal temperatures, health status of the fish and variable clearanc e times from differ ent
organ systems should also be evaluated. Ongoing generation of ncn-compartmentally
modeled numbers could lead to increased precision and accuracy in the pharmacokinetic
database for cold water, marine species . All laboratory results shou ld be validated in the
field tria ls to determin e the efficacy of a given regime under farm condit ions.
Given the practicality of administering antib iotics orally, additional work should be
conducted on improving the bioavailability of these drugs. Identification of co mpounds
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that could increase the uptake of an antibiotic, reduce the interaction wit h divalent
cations, allow for delayed release to the body or that work optimally at pHs found in the
GJ tract are examples of research which would serve to improve the efficacy of a given
reg ime. Considering the high qual ity of fish nutrition work being conducted for the
aquacu lture industry it may be advisable to work with the feed companies to develop
feeds and antibiotic regimes that enhance the delivery of drugs to sick fish.
••
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Append ix 1: Average Weekly Feed Consumption of fish (% body weight I day) by
Individual Tanks
..r 0 ;" 1 1 1 4 S 6 7 . ,
.~..
February 14 1 c~ 3.1 1.1 1.' 1.1 1. 1.5I
Fcbruary l6 1 ~ 3.4 1., 1 .1 1.7 1. 1.66
Feb ruary 21 1
c_
.04 .02 0 0.5
M.=h' 1 ~":g 1.0 1.1 1.1 1.4 0.' 0.2 O. 0 .21
March 13-19 1 He rring 1.0 0.7 0 .7 0. 7 0.' 0.4 O. 0.6
eeuee 6
MaJCh20 -16
':.:urr;ng
ets
27-April 2 2 ~rr:ng O.S 0.3 0.2 1.0 0.7 0.' 0.3 O. 0.3
eis ,
April 3-9 3 Herring t .o 0.' 0.' 1.0 0 .' 0.7 0.3 0 .5
pellets
Apru lO-(6 2 H=U>g 1.0 O.S O.S 0.4 0.4 0.4 0. 1 0.1ll,"
April 17-23 I ChOJl:POO 1.8 I.S
A ril24-30 2 Smelt 1.2 1.0 0 .' 0 .' 0.1 1.0 0.6 1.6
1-7 3 Sme ll 1.' 1.2 1.0 1.6 0 .6 1.1 0.6 1.5I, 3 Smelt 2.6 I., 1.1 2.S 0.' 1.8 2 .44 Smell I. , I. , 1.1 1.7 1.6 1.1 1.26 Sme lt 1.1 1.5 1.2 1.7 1.6 1.0 0. 63 Smelt 1.7 1.5 1.2 1.6 1.6 I.S 1.13 Smelt 1.4 2.0 1.5 1.3 1.8 1.' 0 .753 Smelt 1.0 1.1 1.1 2.3 1.8 2.1 0.23 Smelt 2.0 2.7 21 2.' 2.7 2.S 0 .23 Smelt 2.1 3.0 2.3 3. 1 2.0 2.' O.S
2 Smelt 3.1 3.4 2.6 3.S 3.0 3.2 0. '
1.. 10- 16 3 Smel t 2.' 3.0 2.4 2.6 2.6 2.7 0.'
1ul 17-23 3 Smcl' 2.' 3.0 1.' 2.2 2.' 2.3 O.S
Jul 24-30 2 Smelt 1.6 2.6 1.5 2.3 2.6 I.' 0 .1
l ul 3 1-Au 6 3 Smell 1.6 1., 0 .2
'"
7_13 3 Smell 0.' I. S
A, 14- 20 3 Smell 0.' 1.1
'"
21-27 3 Smell 1.4 1.4
1 ~~r-3 3 Sme ll 1.4 1.'
No te : · riJnentstarteclMa 17, · · Dlfinished Ma 27
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Ap pend ix 2: weight of Fish Used in Pharm. c ok in etic Ex periment.
ORAL DELIVERY: TANK 2
TA G MARCH J MARCH 22
WEIGHT WE IGHT
3180 J2 34
2679 261:5
3316 246 1
2580 2101
18:58 1192
3243 2386
2914 21:51
2411 2363
2:531 2100
21:5:S 2US
7.
TAG
NUMBER
FOO411
FOO468
FOO466
"""'"FOO46O
1N.JEC110N :TMl'J
MARCH;I MARCH 22
WEIGHT WE IGHT
3688 3613
3350 2783
4 14& 3910
:wi9 239:5
2450 163:5
.&06S )140
2943 J06:5
HS6 J)l'
3316 1116
3443 )012
Appendix 3: Temperature Data : Acclimation and Pharmacok inetics Experiment
DATE DAYS TO TANK> TANIO TANI O TANK' TANK' TANKJ
EXPE RIMEN M IN MAX AVG MIN MAX A VG
9503 08 14 6.737 6.902 6.86 6.6S4 6J 145 6.78
950309 13 6.777 6.926 6.87 6.701 6.879 6.80
950JIO 12 6 .827 7.31 7.06 6 .744 7.23 6.99
9503 11 II 6.768 7.37 7.0 1 6 .685 7.31 6.93
950312 10 7. 11 7.44 7.3 1 7.02 7.38 7.25
9503 13 9 7.44 7.52 7.49 7.38 7.45 7.42
9503 14 8 6.77 2 7.78 7.13 6.639 7.74 7.05
950315 7 6.756 7.36 7.22 6 .685 7.3 7. 17
9503 16 6 7.3 7.84 7.73 7.24 7.8 7.68
950317 5 7 .78 8.5 1 8. 18 7.72 8.53 8.13
9503 18 , 8 .34 8.97 8.72 8.3 8.94 8.73
9503 19 , 8.81 9.22 9. 12 8.76 9.18 9.08
9503 20 2 9. 17 9.69 9.S3 9. 12 9.65 9.411
9503 21 1 9.63 9.7 9.68 9.59 9.66 9.63
950322 START 9.68 10.08 9.99 9.64 10.05 9.96
9503 23 10.0 1 10.08 10.04 9.95 10.04 9.99
950 .24 FINISH 9.9 8 10.04 10.0 1 9.93 10.01 9.97
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Appendix 4: 00_ l.8 ve l$ of OTe Adm in iste red Per Os for Individual Fish With
Sam ple calculation
Tat' Wapi V..~OTC ......
,....;., m.. Ocr.i ..fi'"
".
""
' .0 136.1
... ,. ... 134.697' '46. U 134.197. 2101 13 136.1OS,
' 192 r., 133.7
'"
m. i ., 133.7
980 2851 "7 131.298. "63 i.s 135.0
'"
2100 13 136.0
Art~ 134.5
Sample Calcu lation: Fish 984
10.79 g OT Cl50 mI dd H~O
=0.22 g OTCImi dd H~
1.60 mI OTC injected x 1.22 g
-0.3453 g OTC
- 345.3 mg 0 TCl2 615 g fish
- 134 .6 mg OTCIkg fish
7.
Appendix 5: Dose Levels of OTC Admin istered by IP Injecti on fewInd ividua.l Fish
T.. ' ~~ Vol~OTC ......m OT(Jk ri.
471 3616 U DO.I
... "., 1.7 D~_4
... 7970 2.' 133.0
..,
"95 I.' u ao
460 1615 ..• 115.0
" 6 1I«l I., D l .1
'"~ 306' 1.1 112.S
... l 335 2.' 1l1.9
... ll16 I.' 1l 1.6
'~n 112.8
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Appendix 6 : Admini stntion .nd Samp~ TImeti for Ptt-rm _co«ineti c Experiment
D." Tim< ...ee N
•
WedDc:sday. MardI 22 1430 "'~ 9I ~no
"""'"
9
1600 ...... ,
1330 "'~ ,
2010 "'~ , blood sam
2 110 I
"""'"
, bloodsam e
TbllJ'Sday.Marcbll 0230 "' ~ l 12 br blood sam Ie
0'30
"""'"
l 12 hr blood sam le
OSlO "'~ , IS hrblood sample(TomWWJ
'''0 lnlrapo:rilOBeaI
, 18hrrie~sample
Friday. Marcb. 24 0210 p,, ~ l l 6 hr blood sam ple
(Te rminal
0))0 lnmperilDnea.l , l6 hrblood sam ple
(Terminal)
Saturday.Mareh n 1410 "" ~ l 72l1rblood sample(Terminal
ISl O Intraperitoneal l 72hr..;~~ple
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Appendix 7: HPLC Method for Detection of OTC in Cod Fish Serum
Procedur e
1. Aliquot 1 mI of serum or blood into 10 ml teflon centrifug e tubes. If blood has
coagulated weig h out I gm per tu be.
2. Ifspilcing wi th OTC. add dire ctly to serum! blood. vortex .
3. Add 1 mI 20"10Te A-MeOl!. vortex, refrigerate overnight at 4C.
4 . Vort ex agai n then centrifuge at 10.000 rpm for 15 minutes at room temperature.
Use JAlO.l rotor .
5. Pour off supernatant into pre-marked, glass graduated rubes. Evaporate under
nitrogen until fina l volume is 1.0 or 0.5 ml, depending on degree of co ncentra tion
requ ired.
6. Filter extract thro ugh OA5 urn syringe tip filter into HPLC vials, cap and ru n on
nn,c .
ffi>LC Conditions
Column:
Solvent ;
Flow Rate ;
Uv deeector:
Injectio n volume :
Retention Time:
Detection Limit:
Notes
Ultras phereODS 5 um, 4.6" 250 nun. CIS
80"1050mM NaH2 P04 buffer" , pH 25 20"/0 acetonitrile
l.0 ml/ min
353 nm
25 ul
4.9 to 6.7 minute range
0.05 ppm
Standards made up in MeOH ; Use fres h standards each day. Run OTC standards
in MeOH with each run of unknowns. Run occas ional spiked samp le. Use
standards that co mpare in co ncentration to unknowns
If final vo lume is 1.0 ml, express HPLC value as straig ht ppm as measu red by
instru ment, based on appropriate OTC standards. Recovery is 100%.
If final vo lume is less than l. 0 ml, multiply instrument value by volume.
ego1.6 ppm in 0 .7 ml = 1.6 x 0.7 = 1.12 ppm aTC in sample.
Appendix 8: Reco veries of OTC from Sp iked serum SlImples
OT e • 'M.~
33.3 97
16.7 13
3.1 99
1.4 101
O~ ..
OJ lOS
8.
Modoalc l
..
a.s
LS
l.3
' .0
".0
'.0
' .1
' .1
' .1
6.3
7.1
'J
s.,
II
7.'
a
10.2
10. 1
10 . 1
10 .1
..
' .0
1.1
7.1
' .J
, .e
,..
...
, .e
'.7
' .0
:!.3
'I
10.1
10 .1
10.1
10.1
10 .2
10.2
10.2
10 . 1
10.1
10.0
10 .1
10.1
10.1
10 .1
10.1
10.1
10.1
,.-
9-1S
16-"
23 -29
,0.,
6-"
1J-19
2~26
27-$
6-"
1J- 19
2~26
27-2
a-s
10-16
17· 23
24-30
1-7
'Wy
'"'"
April
A.....
Append ix 9: Water Temperature s for Experimental Fish.
Mod uk 7
'0,.
"
"10 .01
10.$
10.1
..
' .7
7.0
s
..
I .'
II
s.,
I .'
7.1
I .'
1-14
15-21
22 -21
,,-'
$· 11
12· 11
19-25
,6-,
J.9
10-16
17-23
a.. ao
"..7· 1J
I""21-27
a.. ,
Note : For detailsOD individual tanktem ~ rduro
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Appendi x 10: Weights of Fish Used In Elimination Experiment.
Ta, Telllperablrt ..w~ Date of We.ipl Wei gbt Weigllt on
Sample!l Final Day Man: b J Man:b 29 FmalDaf
D.
10 1 950527 27$6 2008 2063
10 1 950527 2876 2863 23J7
s s 95060 1 2531 2929 2213
10 s 950601 J731 3102 3392
10 , 950601 3304 33 16 3069
10 s 950601 2733 2771 244'
10 s 95060 1 2812 3 111 2151
, 10 950606 2680 255 2 1968
10 10 950606 272 4 2664 2437
10 10 "0606 2983 196 3 2469
10 20 950616 2493 1576 1518
10 20 950616 1553 1504 1389
10 20 950616 2812 2610 2539
10 20 950616 2848 256 9 2050
2 20 950616 1916 1876 1919
2 20 9506 16 2502 2482 2 181
2 20 950616 3793 355 4 2878
2 20 950616 3004 271 6 2201
10 41 950707 275 3 2542 2154
10 41 950707 4053 303 8 6 542
10 41 950707 2586 2470 2013
2 41 950707 3627 3437 3211
2 41 950707 3099 2148 3680
2 41 950707 27.... 2400 2399
2 41 950707 2518 1879 2078
2 41 950727 26" 2800 2396
10 61 950727 2471 20 57 2793
10 61 950727 2556 2564 3755
10 61 950727 20(5 1S99 2529
2 61 950727 1623 1624 2135
2 61 950727 2868 274 9 2923
s 61 950727
2 101 950905 ....9 455 1 3937
2 101 950'Xl5 214 7 1'96 2il l
2 101 950'Xl5 2958 2698 3312
2 101 950'Xl5 3035 2939 2286
2 10 1 95090'
2 101 950905 3519 2868 2718
10 101 950905 3618 3554 3429
10 101 950905 2806 2623 1887
10 101 950905 2967 2669 2754
10 101 950905 2904 2231 3250
Sam Ie Da A~ Wci . 2853 260' 2557
8'
Appendix 11: Su b Weights of Fish for Elimination Experiment
Tag # Ori~~eig.br P7~eight Wei ghrD ifference
951 2482 2332 -1 50
' 99 455 1 446 1 -90
SSS 1876 1850 -26
.59 2573 2SOQ -73
586 34] 7 3389 48
582 17% 1736 -OQ
'83 2749 2721 -28
"I 1702 168 1 -2 1
' 96 2363 2334 -29
831 3554 )5 0 1 -53
Ave ra e 2108 2650 -58
8J
Appendix 12: Water Temperatul'1! Profi le: Bay Bu lls, NF Fann Site , Jul y to
November, 1~
Bay Bulls.NF. -ax1_ -15. 95 17:00 '00 ZO/08
Sea Forest PlaDtIlion Ltd. . 1n1"", . - 0 .35 23:00 '00 Z3/0'
,
N$-JjOSH no. 0067'5 ~." - 9.~9
~
_iJliur~• . _ 1782
"
"
"
r'\;d e-.
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1 ~ ' i W' Vlr1
)/ I I I -,
" I~ I T ........... l
o· \··../4a.~-+ "'\...v-l'\II'1
'V\nn
,
f--- O.O'l ' °t;.f. b------>
.
t'c.
Ju l y - No vember 1994 r . McKee ver
••
9.7 8.7 8.5 l.0
9.6 5.7 5.8 3.9
9.7 3.7 6 .0
9.7 1.9 7 .8
Da 41
Da 61
Dav t01
Appendix 13 : Water Temperatures, and Differences Between the Temperature
Groups, for the 1G-c, 10-<: DecNasing to 2-c an d Control Tanks
Daw IOC t OC to2 C e-trul Dif't Betw_ Tem C .... ,
May 17,1995 9.9 9.9 9 .9 0 .0
May 21, l99 5 t oe 10 .1 10.0 0.0
to.z 10.0 10 .0 0.2
9.9 9.4 9.4 0 .5
I S
Appendix 14: Number of Fish Samp led Per Sample Day for the Elim inat ion
Expe rim ent
Commo o tO C IOCdecreasiag Coafro l
TaD_ratun: ~lC
0 I ,
D~ ' s I0." , I
10 , s
Da 41 , ,
Da 61 , s I
Da 101 6 6 I
ToW 16 11 11 ,
86




